ID   5HT2A_HUMAN             Reviewed;         471 AA.
AC   P28223; B2RAC5; B4DZ79; F5GWE8; Q5T8C0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   07-OCT-2020, entry version 208.
DE   RecName: Full=5-hydroxytryptamine receptor 2A;
DE            Short=5-HT-2;
DE            Short=5-HT-2A;
DE   AltName: Full=Serotonin receptor 2A;
GN   Name=HTR2A; Synonyms=HTR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain stem;
RX   PubMed=1722404; DOI=10.1016/0006-291x(91)92105-s;
RA   Saltzman A.G., Morse B., Whitman M.M., Ivanshchenko Y., Jaye M., Felder S.;
RT   "Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes.";
RL   Biochem. Biophys. Res. Commun. 181:1469-1478(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1323014; DOI=10.1016/0169-328x(92)90005-v;
RA   Chen K., Yang W., Grimsby J., Shih J.C.;
RT   "The human 5-HT2 receptor is encoded by a multiple intron-exon gene.";
RL   Brain Res. Mol. Brain Res. 14:20-26(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Platelet;
RX   PubMed=8035173; DOI=10.1046/j.1471-4159.1994.63020465.x;
RA   Cook E.H. Jr., Fletcher K.E., Wainwright M., Marks N., Yan S.Y.,
RA   Leventhal B.L.;
RT   "Primary structure of the human platelet serotonin 5-HT2A receptor:
RT   identify with frontal cortex serotonin 5-HT2A receptor.";
RL   J. Neurochem. 63:465-469(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 9-464 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Tritch R.J., Robinson D.L., Sahagan B.G., Horlick R.A.;
RT   "Cloning and nucleotide sequence of the human(5HT) type 2 receptor.";
RL   Submitted (MAY-1992) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 105-218, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=1330647; DOI=10.1016/0922-4106(92)90123-d;
RA   Stam N.J., van Huizen F., van Alebeek C., Brands J., Dijkema R.,
RA   Tonnaer J.A., Olijve W.;
RT   "Genomic organization, coding sequence and functional expression of human
RT   5-HT2 and 5-HT1A receptor genes.";
RL   Eur. J. Pharmacol. 227:153-162(1992).
RN   [11]
RP   INTERACTION WITH MPDZ.
RX   PubMed=11150294; DOI=10.1074/jbc.m008089200;
RA   Becamel C., Figge A., Poliak S., Dumuis A., Peles E., Bockaert J.,
RA   Luebbert H., Ullmer C.;
RT   "Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10
RT   of the multi-PDZ domain protein MUPP1.";
RL   J. Biol. Chem. 276:12974-12982(2001).
RN   [12]
RP   INTERACTION WITH PATJ; MPP3; PRDX6; DLG4; DLG1; CASK; APBA1 AND MAGI2, AND
RP   MUTAGENESIS OF GLY-463; ASN-465; CYS-470 AND VAL-471.
RX   PubMed=14988405; DOI=10.1074/jbc.m312106200;
RA   Becamel C., Gavarini S., Chanrion B., Alonso G., Galeotti N., Dumuis A.,
RA   Bockaert J., Marin P.;
RT   "The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of
RT   PDZ proteins.";
RL   J. Biol. Chem. 279:20257-20266(2004).
RN   [13]
RP   REVIEW.
RX   PubMed=18476671; DOI=10.1021/cr078224o;
RA   Nichols D.E., Nichols C.D.;
RT   "Serotonin receptors.";
RL   Chem. Rev. 108:1614-1641(2008).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18703043; DOI=10.1016/j.ejphar.2008.07.040;
RA   Cussac D., Boutet-Robinet E., Ailhaud M.C., Newman-Tancredi A.,
RA   Martel J.C., Danty N., Rauly-Lestienne I.;
RT   "Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and
RT   5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in
RT   CHO cells.";
RL   Eur. J. Pharmacol. 594:32-38(2008).
RN   [15]
RP   INTERACTION WITH GRM2, FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18297054; DOI=10.1038/nature06612;
RA   Gonzalez-Maeso J., Ang R.L., Yuen T., Chan P., Weisstaub N.V.,
RA   Lopez-Gimenez J.F., Zhou M., Okawa Y., Callado L.F., Milligan G.,
RA   Gingrich J.A., Filizola M., Meana J.J., Sealfon S.C.;
RT   "Identification of a serotonin/glutamate receptor complex implicated in
RT   psychosis.";
RL   Nature 452:93-97(2008).
RN   [16]
RP   FUNCTION.
RX   PubMed=19057895; DOI=10.1007/s00210-008-0378-4;
RA   Knauer C.S., Campbell J.E., Chio C.L., Fitzgerald L.W.;
RT   "Pharmacological characterization of mitogen-activated protein kinase
RT   activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.";
RL   Naunyn Schmiedebergs Arch. Pharmacol. 379:461-471(2009).
RN   [17]
RP   INTERACTION WITH DRD2, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21645528; DOI=10.1016/j.neuropharm.2011.05.023;
RA   Albizu L., Holloway T., Gonzalez-Maeso J., Sealfon S.C.;
RT   "Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine
RT   D2 receptors.";
RL   Neuropharmacology 61:770-777(2011).
RN   [18]
RP   REVIEW.
RX   PubMed=20945968; DOI=10.33549/physiolres.931903;
RA   Pytliak M., Vargova V., Mechirova V., Felsoci M.;
RT   "Serotonin receptors - from molecular biology to clinical applications.";
RL   Physiol. Res. 60:15-25(2011).
RN   [19]
RP   INTERACTION WITH GRM2, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22300836; DOI=10.1016/j.neuropharm.2012.01.010;
RA   Delille H.K., Becker J.M., Burkhardt S., Bleher B., Terstappen G.C.,
RA   Schmidt M., Meyer A.H., Unger L., Marek G.J., Mezler M.;
RT   "Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular
RT   signaling cascades.";
RL   Neuropharmacology 62:2184-2191(2012).
RN   [20]
RP   PHOSPHORYLATION AT SER-280, AND MUTAGENESIS OF SER-280.
RX   PubMed=24637012; DOI=10.1074/mcp.m113.036558;
RA   Karaki S., Becamel C., Murat S., Mannoury la Cour C., Millan M.J.,
RA   Prezeau L., Bockaert J., Marin P., Vandermoere F.;
RT   "Quantitative phosphoproteomics unravels biased phosphorylation of
RT   serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic
RT   agonists.";
RL   Mol. Cell. Proteomics 13:1273-1285(2014).
RN   [21]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=24089568; DOI=10.1128/jvi.02252-13;
RA   Assetta B., Maginnis M.S., Gracia Ahufinger I., Haley S.A., Gee G.V.,
RA   Nelson C.D., O'Hara B.A., Allen Ramdial S.A., Atwood W.J.;
RT   "5-HT2 receptors facilitate JC polyomavirus entry.";
RL   J. Virol. 87:13490-13498(2013).
RN   [22]
RP   FUNCTION, AND MUTAGENESIS OF LEU-229.
RX   PubMed=28129538; DOI=10.1016/j.cell.2016.12.033;
RA   Wacker D., Wang S., McCorvy J.D., Betz R.M., Venkatakrishnan A.J.,
RA   Levit A., Lansu K., Schools Z.L., Che T., Nichols D.E., Shoichet B.K.,
RA   Dror R.O., Roth B.L.;
RT   "Crystal structure of an LSD-bound human serotonin receptor.";
RL   Cell 168:377-389(2017).
RN   [23]
RP   VARIANTS ASN-25 AND TYR-452.
RX   PubMed=8655141; DOI=10.1007/bf02281871;
RA   Erdmann J., Shimron-Abarbanell D., Rietschel M., Albus M., Maier W.,
RA   Koerner J., Bondy B., Chen K., Shih J.C., Knapp M., Propping P.,
RA   Noethen M.M.;
RT   "Systematic screening for mutations in the human serotonin-2A (5-HT2A)
RT   receptor gene: identification of two naturally occurring receptor variants
RT   and association analysis in schizophrenia.";
RL   Hum. Genet. 97:614-619(1996).
RN   [24]
RP   VARIANTS ASN-25 AND TYR-452.
RX   PubMed=10581480;
RX   DOI=10.1002/(sici)1096-8628(19991215)88:6<621::aid-ajmg9>3.0.co;2-h;
RA   Marshall S.E., Bird T.G., Hart K., Welsh K.I.;
RT   "Unified approach to the analysis of genetic variation in serotonergic
RT   pathways.";
RL   Am. J. Med. Genet. 88:621-627(1999).
RN   [25]
RP   VARIANTS VAL-197; VAL-447 AND TYR-452.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions of
RT   human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [26]
RP   ERRATUM OF PUBMED:10391209.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine
CC       (serotonin) (PubMed:1330647, PubMed:18703043, PubMed:19057895). Also
CC       functions as a receptor for various drugs and psychoactive substances,
CC       including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-
CC       aminopropane (DOI) and lysergic acid diethylamide (LSD)
CC       (PubMed:28129538). Ligand binding causes a conformation change that
CC       triggers signaling via guanine nucleotide-binding proteins (G proteins)
CC       and modulates the activity of down-stream effectors (PubMed:28129538).
CC       Beta-arrestin family members inhibit signaling via G proteins and
CC       mediate activation of alternative signaling pathways (PubMed:28129538).
CC       Signaling activates phospholipase C and a phosphatidylinositol-calcium
CC       second messenger system that modulates the activity of
CC       phosphatidylinositol 3-kinase and promotes the release of Ca(2+) ions
CC       from intracellular stores (PubMed:18703043, PubMed:28129538). Affects
CC       neural activity, perception, cognition and mood (PubMed:18297054).
CC       Plays a role in the regulation of behavior, including responses to
CC       anxiogenic situations and psychoactive substances. Plays a role in
CC       intestinal smooth muscle contraction, and may play a role in arterial
CC       vasoconstriction. {ECO:0000269|PubMed:1330647,
CC       ECO:0000269|PubMed:18297054, ECO:0000269|PubMed:18703043,
CC       ECO:0000269|PubMed:19057895, ECO:0000269|PubMed:21645528,
CC       ECO:0000269|PubMed:22300836, ECO:0000269|PubMed:28129538}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for human JC
CC       polyomavirus/JCPyV. {ECO:0000269|PubMed:24089568}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with MPDZ and PATJ
CC       (PubMed:11150294, PubMed:14988405). May interact (via C-terminus) with
CC       MPP3, PRDX6, DLG4, DLG1, CASK, APBA1 and MAGI2 (PubMed:14988405).
CC       Interacts with GRM2 and DRD2; this may affect signaling
CC       (PubMed:18297054, PubMed:21645528, PubMed:22300836).
CC       {ECO:0000269|PubMed:11150294, ECO:0000269|PubMed:14988405,
CC       ECO:0000269|PubMed:18297054, ECO:0000269|PubMed:21645528,
CC       ECO:0000269|PubMed:22300836}.
CC   -!- INTERACTION:
CC       P28223; P08908: HTR1A; NbExp=3; IntAct=EBI-6656333, EBI-6570214;
CC       P28223; P28223: HTR2A; NbExp=3; IntAct=EBI-6656333, EBI-6656333;
CC       P28223; P41595: HTR2B; NbExp=3; IntAct=EBI-6656333, EBI-7474947;
CC       P28223; P28335: HTR2C; NbExp=5; IntAct=EBI-6656333, EBI-994141;
CC       P28223-1; P21554: CNR1; NbExp=2; IntAct=EBI-15573967, EBI-2909859;
CC       P28223-1; Q14416: GRM2; NbExp=4; IntAct=EBI-15573967, EBI-10232876;
CC       P28223-1; P28335-1: HTR2C; NbExp=3; IntAct=EBI-15573967, EBI-21299643;
CC       P28223-1; P18654: Rps6ka3; Xeno; NbExp=2; IntAct=EBI-15573967, EBI-397744;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:28129538};
CC       Multi-pass membrane protein {ECO:0000305}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:P35363}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:P14842}. Cytoplasmic vesicle
CC       {ECO:0000250|UniProtKB:P14842}. Membrane, caveola
CC       {ECO:0000250|UniProtKB:P14842}. Cell junction, synapse, presynapse
CC       {ECO:0000250|UniProtKB:P14842}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28223-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28223-2; Sequence=VSP_046663;
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex (at protein level).
CC       Detected in blood platelets. {ECO:0000269|PubMed:18297054}.
CC   -!- DOMAIN: The PDZ domain-binding motif is involved in the interaction
CC       with PATJ, CASK, APBA1, DLG1 and DLG4. {ECO:0000269|PubMed:11150294,
CC       ECO:0000269|PubMed:14988405}.
CC   -!- MISCELLANEOUS: Binds lysergic acid diethylamine (LSD) in the
CC       orthosteric pocket (Probable). Bound LSD dissociates extremely slowly,
CC       with a residence time of about 221 minutes at 37 degrees Celsius.
CC       {ECO:0000269|PubMed:28129538}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HTR2A";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57830; CAA40963.1; -; mRNA.
DR   EMBL; S42168; AAB22791.2; -; Genomic_DNA.
DR   EMBL; S42165; AAB22791.2; JOINED; Genomic_DNA.
DR   EMBL; S42167; AAB22791.2; JOINED; Genomic_DNA.
DR   EMBL; S71229; AAB31320.1; -; mRNA.
DR   EMBL; AF498982; AAM21129.1; -; mRNA.
DR   EMBL; AK302787; BAG63991.1; -; mRNA.
DR   EMBL; AK314132; BAG36822.1; -; mRNA.
DR   EMBL; AL160397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136958; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08770.1; -; Genomic_DNA.
DR   EMBL; BC069356; AAH69356.1; -; mRNA.
DR   EMBL; BC069576; AAH69576.1; -; mRNA.
DR   EMBL; BC074848; AAH74848.1; -; mRNA.
DR   EMBL; BC074849; AAH74849.1; -; mRNA.
DR   EMBL; BC096839; AAH96839.1; -; mRNA.
DR   EMBL; M86841; AAA58354.1; -; mRNA.
DR   EMBL; S50130; AAB24166.2; -; Genomic_DNA.
DR   EMBL; S49737; AAB24166.2; JOINED; Genomic_DNA.
DR   EMBL; S50113; AAB24166.2; JOINED; Genomic_DNA.
DR   CCDS; CCDS9405.1; -. [P28223-1]
DR   PIR; A43956; A43956.
DR   RefSeq; NP_000612.1; NM_000621.4. [P28223-1]
DR   RefSeq; NP_001159419.1; NM_001165947.2.
DR   PDB; 6A93; X-ray; 3.00 A; A/B=70-265, A/B=313-403.
DR   PDB; 6A94; X-ray; 2.90 A; A/B=70-265, A/B=313-403.
DR   PDBsum; 6A93; -.
DR   PDBsum; 6A94; -.
DR   SMR; P28223; -.
DR   BioGRID; 109588; 7.
DR   DIP; DIP-41844N; -.
DR   IntAct; P28223; 21.
DR   MINT; P28223; -.
DR   STRING; 9606.ENSP00000437737; -.
DR   ChEMBL; CHEMBL224; -.
DR   DrugBank; DB13940; 2,5-Dimethoxy-4-ethylthioamphetamine.
DR   DrugBank; DB01537; 4-Bromo-2,5-dimethoxyphenethylamine.
DR   DrugBank; DB14010; 5-methoxy-N,N-dimethyltryptamine.
DR   DrugBank; DB01614; Acepromazine.
DR   DrugBank; DB06288; Amisulpride.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00543; Amoxapine.
DR   DrugBank; DB08927; Amperozide.
DR   DrugBank; DB04599; Aniracetam.
DR   DrugBank; DB05227; APD791.
DR   DrugBank; DB00714; Apomorphine.
DR   DrugBank; DB01238; Aripiprazole.
DR   DrugBank; DB14185; Aripiprazole lauroxil.
DR   DrugBank; DB06216; Asenapine.
DR   DrugBank; DB05687; BL-1020.
DR   DrugBank; DB09223; Blonanserin.
DR   DrugBank; DB09128; Brexpiprazole.
DR   DrugBank; DB01200; Bromocriptine.
DR   DrugBank; DB09016; Butriptyline.
DR   DrugBank; DB00248; Cabergoline.
DR   DrugBank; DB09061; Cannabidiol.
DR   DrugBank; DB06016; Cariprazine.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB08810; Cinitapride.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00924; Cyclobenzaprine.
DR   DrugBank; DB00434; Cyproheptadine.
DR   DrugBank; DB06512; Deramciclane.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB11273; Dihydroergocornine.
DR   DrugBank; DB13345; Dihydroergocristine.
DR   DrugBank; DB01488; Dimethyltryptamine.
DR   DrugBank; DB00843; Donepezil.
DR   DrugBank; DB09167; Dosulepin.
DR   DrugBank; DB06446; Dotarizine.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB05492; Epicept NP-1.
DR   DrugBank; DB00751; Epinastine.
DR   DrugBank; DB12177; Eplivanserin.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00696; Ergotamine.
DR   DrugBank; DB01175; Escitalopram.
DR   DrugBank; DB06678; Esmirtazapine.
DR   DrugBank; DB09194; Etoperidone.
DR   DrugBank; DB00574; Fenfluramine.
DR   DrugBank; DB04908; Flibanserin.
DR   DrugBank; DB00875; Flupentixol.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB04842; Fluspirilene.
DR   DrugBank; DB12141; Gilteritinib.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB05079; HY10275.
DR   DrugBank; DB04946; Iloperidone.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB12465; Ketanserin.
DR   DrugBank; DB00555; Lamotrigine.
DR   DrugBank; DB00589; Lisuride.
DR   DrugBank; DB09195; Lorpiprazole.
DR   DrugBank; DB00408; Loxapine.
DR   DrugBank; DB06077; Lumateperone.
DR   DrugBank; DB08815; Lurasidone.
DR   DrugBank; DB00934; Maprotiline.
DR   DrugBank; DB14009; Medical Cannabis.
DR   DrugBank; DB00933; Mesoridazine.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB00247; Methysergide.
DR   DrugBank; DB06148; Mianserin.
DR   DrugBank; DB01454; Midomafetamine.
DR   DrugBank; DB00805; Minaprine.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01442; MMDA.
DR   DrugBank; DB01618; Molindone.
DR   DrugBank; DB13948; N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
DR   DrugBank; DB14011; Nabiximols.
DR   DrugBank; DB01149; Nefazodone.
DR   DrugBank; DB12555; Nelotanserin.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB06229; Ocaperidone.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB01267; Paliperidone.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB01186; Pergolide.
DR   DrugBank; DB08922; Perospirone.
DR   DrugBank; DB05316; Pimavanserin.
DR   DrugBank; DB09286; Pipamperone.
DR   DrugBank; DB01621; Pipotiazine.
DR   DrugBank; DB06153; Pizotifen.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB00777; Propiomazine.
DR   DrugBank; DB01224; Quetiapine.
DR   DrugBank; DB00409; Remoxipride.
DR   DrugBank; DB00734; Risperidone.
DR   DrugBank; DB12693; Ritanserin.
DR   DrugBank; DB12163; Sarpogrelate.
DR   DrugBank; DB08839; Serotonin.
DR   DrugBank; DB06144; Sertindole.
DR   DrugBank; DB09304; Setiptiline.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB01622; Thioproperazine.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB01623; Thiothixene.
DR   DrugBank; DB13025; Tiapride.
DR   DrugBank; DB00656; Trazodone.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB06109; YKP-1358.
DR   DrugBank; DB01392; Yohimbine.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugBank; DB09225; Zotepine.
DR   DrugBank; DB01624; Zuclopenthixol.
DR   DrugCentral; P28223; -.
DR   GuidetoPHARMACOLOGY; 6; -.
DR   GlyGen; P28223; 5 sites.
DR   iPTMnet; P28223; -.
DR   PhosphoSitePlus; P28223; -.
DR   BioMuta; HTR2A; -.
DR   DMDM; 543727; -.
DR   MassIVE; P28223; -.
DR   PaxDb; P28223; -.
DR   PeptideAtlas; P28223; -.
DR   PRIDE; P28223; -.
DR   ProteomicsDB; 24094; -.
DR   ProteomicsDB; 54453; -. [P28223-1]
DR   Antibodypedia; 2927; 360 antibodies.
DR   Ensembl; ENST00000378688; ENSP00000367959; ENSG00000102468. [P28223-1]
DR   Ensembl; ENST00000542664; ENSP00000437737; ENSG00000102468. [P28223-1]
DR   Ensembl; ENST00000543956; ENSP00000441861; ENSG00000102468. [P28223-2]
DR   GeneID; 3356; -.
DR   KEGG; hsa:3356; -.
DR   UCSC; uc001vbr.5; human. [P28223-1]
DR   CTD; 3356; -.
DR   DisGeNET; 3356; -.
DR   EuPathDB; HostDB:ENSG00000102468.10; -.
DR   GeneCards; HTR2A; -.
DR   HGNC; HGNC:5293; HTR2A.
DR   HPA; ENSG00000102468; Tissue enriched (brain).
DR   MalaCards; HTR2A; -.
DR   MIM; 182135; gene.
DR   neXtProt; NX_P28223; -.
DR   OpenTargets; ENSG00000102468; -.
DR   PharmGKB; PA193; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00960000186619; -.
DR   HOGENOM; CLU_009579_11_3_1; -.
DR   InParanoid; P28223; -.
DR   KO; K04157; -.
DR   OMA; RLYNNDF; -.
DR   OrthoDB; 962038at2759; -.
DR   PhylomeDB; P28223; -.
DR   TreeFam; TF316350; -.
DR   PathwayCommons; P28223; -.
DR   Reactome; R-HSA-390666; Serotonin receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   SignaLink; P28223; -.
DR   SIGNOR; P28223; -.
DR   BioGRID-ORCS; 3356; 2 hits in 871 CRISPR screens.
DR   GeneWiki; 5-HT2A_receptor; -.
DR   GenomeRNAi; 3356; -.
DR   Pharos; P28223; Tclin.
DR   PRO; PR:P28223; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; P28223; protein.
DR   Bgee; ENSG00000102468; Expressed in dorsolateral prefrontal cortex and 158 other tissues.
DR   ExpressionAtlas; P28223; baseline and differential.
DR   Genevisible; P28223; HS.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0070852; C:cell body fiber; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071886; F:1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0004993; F:G protein-coupled serotonin receptor activity; IDA:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0051378; F:serotonin binding; IDA:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007202; P:activation of phospholipase C activity; IDA:UniProtKB.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0014824; P:artery smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0048148; P:behavioral response to cocaine; IEA:Ensembl.
DR   GO; GO:0008219; P:cell death; IEA:Ensembl.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007187; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; IBA:GO_Central.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0051967; P:negative regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; IDA:UniProtKB.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007208; P:phospholipase C-activating serotonin receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; IEA:Ensembl.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0010513; P:positive regulation of phosphatidylinositol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0044380; P:protein localization to cytoskeleton; IEA:Ensembl.
DR   GO; GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IDA:UniProtKB.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030431; P:sleep; IEA:Ensembl.
DR   GO; GO:0001659; P:temperature homeostasis; IEA:Ensembl.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; IEA:Ensembl.
DR   InterPro; IPR000455; 5HT2A_rcpt.
DR   InterPro; IPR002231; 5HT_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24247:SF30; PTHR24247:SF30; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00516; 5HT2ARECEPTR.
DR   PRINTS; PR01101; 5HTRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Behavior; Cell junction; Cell membrane;
KW   Cell projection; Cytoplasmic vesicle; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction; Membrane;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Synapse;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..471
FT                   /note="5-hydroxytryptamine receptor 2A"
FT                   /id="PRO_0000068946"
FT   TOPO_DOM        1..75
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        76..99
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        100..110
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        111..132
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        133..148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        149..171
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        172..191
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        192..215
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        216..233
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        234..254
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        255..324
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        325..346
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        347..362
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        363..384
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        385..471
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   REGION          155..160
FT                   /note="Agonist binding"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   REGION          336..340
FT                   /note="Agonist binding"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           172..174
FT                   /note="DRY motif; important for ligand-induced conformation
FT                   changes"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           376..380
FT                   /note="NPxxY motif; important for ligand-induced
FT                   conformation changes and signaling"
FT                   /evidence="ECO:0000250|UniProtKB:P41595"
FT   MOTIF           469..471
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000269|PubMed:11150294,
FT                   ECO:0000269|PubMed:14988405"
FT   SITE            229
FT                   /note="Hydrophobic barrier that decreases the speed of
FT                   ligand binding and dissociation"
FT                   /evidence="ECO:0000269|PubMed:28129538"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:24637012"
FT   CARBOHYD        8
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        51
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        148..227
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        349..353
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VAR_SEQ         1..138
FT                   /note="MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENR
FT                   TNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNY
FT                   FLMSLAIADMLLGFLVMPVSMLTILYG -> MQFLKSAKQKPNYYHIMLVEDQEEGTLH
FT                   QFNYCERCSESQNNKCISCVDPEDKW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046663"
FT   VARIANT         25
FT                   /note="T -> N (in dbSNP:rs1805055)"
FT                   /evidence="ECO:0000269|PubMed:10581480,
FT                   ECO:0000269|PubMed:8655141"
FT                   /id="VAR_003448"
FT   VARIANT         197
FT                   /note="I -> V (in dbSNP:rs6304)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_013901"
FT   VARIANT         447
FT                   /note="A -> V (in dbSNP:rs6308)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_013902"
FT   VARIANT         452
FT                   /note="H -> Y (in dbSNP:rs6314)"
FT                   /evidence="ECO:0000269|PubMed:10391209,
FT                   ECO:0000269|PubMed:10581480, ECO:0000269|PubMed:8655141"
FT                   /id="VAR_003449"
FT   MUTAGEN         229
FT                   /note="L->A: Strongly increases dissociation of bound
FT                   lysergic acid diethylamine, without affecting binding
FT                   affinity. Reduces signaling via arrestins, but has no
FT                   effect on signaling via the phosphatidylinositol-calcium
FT                   second messenger system."
FT                   /evidence="ECO:0000269|PubMed:28129538"
FT   MUTAGEN         280
FT                   /note="S->A: Increased ability of hallucinogens to
FT                   desensitize the receptor."
FT                   /evidence="ECO:0000269|PubMed:24637012"
FT   MUTAGEN         280
FT                   /note="S->D: Reduced receptor desensitization by
FT                   nonhallucinogenic agonists."
FT                   /evidence="ECO:0000269|PubMed:24637012"
FT   MUTAGEN         463
FT                   /note="G->V: Loss of interaction with PATJ."
FT                   /evidence="ECO:0000269|PubMed:14988405"
FT   MUTAGEN         465
FT                   /note="N->S: No effect on interaction with PATJ. Acquires
FT                   the binding properties of HTR2C; when associated with S-
FT                   470."
FT                   /evidence="ECO:0000269|PubMed:14988405"
FT   MUTAGEN         470
FT                   /note="C->S: No effect on interaction with PATJ. Acquires
FT                   the binding properties of HTR2C; when associated with S-
FT                   465."
FT                   /evidence="ECO:0000269|PubMed:14988405"
FT   MUTAGEN         471
FT                   /note="V->A: Loss of interaction with PATJ, CASK, APBA1,
FT                   DLG1 and DLG4."
FT                   /evidence="ECO:0000269|PubMed:14988405"
FT   HELIX           70..101
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           103..105
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           108..126
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           128..136
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   TURN            137..139
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           146..177
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   TURN            180..183
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           189..207
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           209..216
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   TURN            219..221
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   STRAND          226..228
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           232..242
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           244..265
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           313..348
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   TURN            350..352
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           355..383
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   HELIX           385..395
FT                   /evidence="ECO:0000244|PDB:6A94"
FT   CONFLICT        P28223-2:49
FT                   /note="D -> N (in Ref. 5; BAG63991)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   471 AA;  52603 MW;  EF8AAC0BC5379DA2 CRC64;
     MDILCEENTS LSSTTNSLMQ LNDDTRLYSN DFNSGEANTS DAFNWTVDSE NRTNLSCEGC
     LSPSCLSLLH LQEKNWSALL TAVVIILTIA GNILVIMAVS LEKKLQNATN YFLMSLAIAD
     MLLGFLVMPV SMLTILYGYR WPLPSKLCAV WIYLDVLFST ASIMHLCAIS LDRYVAIQNP
     IHHSRFNSRT KAFLKIIAVW TISVGISMPI PVFGLQDDSK VFKEGSCLLA DDNFVLIGSF
     VSFFIPLTIM VITYFLTIKS LQKEATLCVS DLGTRAKLAS FSFLPQSSLS SEKLFQRSIH
     REPGSYTGRR TMQSISNEQK ACKVLGIVFF LFVVMWCPFF ITNIMAVICK ESCNEDVIGA
     LLNVFVWIGY LSSAVNPLVY TLFNKTYRSA FSRYIQCQYK ENKKPLQLIL VNTIPALAYK
     SSQLQMGQKK NSKQDAKTTD NDCSMVALGK QHSEEASKDN SDGVNEKVSC V
//
ID   APJ_HUMAN               Reviewed;         380 AA.
AC   P35414;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   07-OCT-2020, entry version 181.
DE   RecName: Full=Apelin receptor;
DE   AltName: Full=Angiotensin receptor-like 1;
DE   AltName: Full=G-protein coupled receptor APJ;
DE   AltName: Full=G-protein coupled receptor HG11;
GN   Name=APLNR; Synonyms=AGTRL1, APJ;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=8294032; DOI=10.1016/0378-1119(93)90495-o;
RA   O'Dowd B.F., Heiber M., Chan A., Heng H.H.Q., Tsui L.-C., Kennedy J.L.,
RA   Shi X., Petronis A., George S.R., Nguyen T.;
RT   "A human gene that shows identity with the gene encoding the angiotensin
RT   receptor is located on chromosome 11.";
RL   Gene 136:355-360(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Eggerickx D., Schurmans S., Vassart G., Parmentier M.;
RT   "Molecular cloning and tissue distribution of a human orphan receptor
RT   belonging to the G protein coupled receptors family.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND FUNCTION (MICROBIAL INFECTION).
RX   PubMed=11090199; DOI=10.1128/jvi.74.24.11972-11976.2000;
RA   Cayabyab M., Hinuma S., Farzan M., Choe H., Fukusumi S., Kitada C.,
RA   Nishizawa N., Hosoya M., Nishimura O., Messele T., Pollakis G.,
RA   Goudsmit J., Fujino M., Sodroski J.;
RT   "Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ,
RT   inhibits human immunodeficiency virus type 1 entry.";
RL   J. Virol. 74:11972-11976(2000).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25639753; DOI=10.1038/srep08170;
RA   Wang Z., Yu D., Wang M., Wang Q., Kouznetsova J., Yang R., Qian K., Wu W.,
RA   Shuldiner A., Sztalryd C., Zou M., Zheng W., Gong D.W.;
RT   "Elabela-apelin receptor signaling pathway is functional in mammalian
RT   systems.";
RL   Sci. Rep. 5:8170-8170(2015).
RN   [6]
RP   FUNCTION.
RX   PubMed=28137936; DOI=10.1161/circulationaha.116.023218;
RA   Yang P., Read C., Kuc R.E., Buonincontri G., Southwood M., Torella R.,
RA   Upton P.D., Crosby A., Sawiak S.J., Carpenter T.A., Glen R.C.,
RA   Morrell N.W., Maguire J.J., Davenport A.P.;
RT   "Elabela/Toddler is an endogenous agonist of the apelin APJ receptor in the
RT   adult cardiovascular system, and exogenous administration of the peptide
RT   compensates for the downregulation of its expression in pulmonary arterial
RT   hypertension.";
RL   Circulation 135:1160-1173(2017).
CC   -!- FUNCTION: Receptor for apelin receptor early endogenous ligand (APELA)
CC       and apelin (APLN) hormones coupled to G proteins that inhibit adenylate
CC       cyclase activity (PubMed:11090199, PubMed:25639753, PubMed:28137936).
CC       Plays a key role in early development such as gastrulation, blood
CC       vessels formation and heart morphogenesis by acting as a receptor for
CC       APELA hormone (By similarity). May promote angioblast migration toward
CC       the embryonic midline, i.e. the position of the future vessel
CC       formation, during vasculogenesis (By similarity). Promotes sinus
CC       venosus (SV)-derived endothelial cells migration into the developing
CC       heart to promote coronary blood vessel development (By similarity).
CC       Plays also a role in various processes in adults such as regulation of
CC       blood vessel formation, blood pressure, heart contractility and heart
CC       failure (PubMed:25639753, PubMed:28137936).
CC       {ECO:0000250|UniProtKB:P79960, ECO:0000250|UniProtKB:Q7SZP9,
CC       ECO:0000250|UniProtKB:Q9WV08, ECO:0000269|PubMed:11090199,
CC       ECO:0000269|PubMed:25639753, ECO:0000269|PubMed:28137936}.
CC   -!- FUNCTION: (Microbial infection) Alternative coreceptor with CD4 for
CC       HIV-1 infection; may be involved in the development of AIDS dementia
CC       (PubMed:11090199). {ECO:0000269|PubMed:11090199}.
CC   -!- INTERACTION:
CC       P35414; P30556: AGTR1; NbExp=14; IntAct=EBI-2875891, EBI-6623016;
CC       P35414; P29033: GJB2; NbExp=3; IntAct=EBI-2875891, EBI-3905204;
CC       P35414; P41145: OPRK1; NbExp=3; IntAct=EBI-2875891, EBI-925028;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25639753}.
CC       Note=After exposure to apelin (APLN), internalized from the cell
CC       surface into an endosomal recycling compartment, from where it is
CC       recycled to the cell membrane (By similarity). After exposure to apelin
CC       receptor early endogenous ligand (APELA), internalized from the cell
CC       surface into an endosomal recycling compartment, from where it is
CC       recycled to the cell membrane (PubMed:25639753).
CC       {ECO:0000250|UniProtKB:Q9JHG3, ECO:0000269|PubMed:25639753}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, kidney, stomach, spleen,
CC       thymus, lung, ovary, small intestine and colon, adipose tissues and
CC       pancreas (PubMed:8294032, PubMed:25639753). Expressed in glial cells,
CC       astrocytes and neuronal subpopulations (PubMed:8294032). Expressed in
CC       embryonic (ESCs) and induced (iPSCs) pluripotent stem cells
CC       (PubMed:25639753). {ECO:0000269|PubMed:25639753,
CC       ECO:0000269|PubMed:8294032}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/APLNRID44364ch11q12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03642; AAA18954.1; -; Genomic_DNA.
DR   EMBL; X89271; CAA61546.1; -; mRNA.
DR   EMBL; BC032688; AAH32688.1; -; mRNA.
DR   CCDS; CCDS7950.1; -.
DR   PIR; I38435; I38435.
DR   RefSeq; NP_005152.1; NM_005161.4.
DR   PDB; 2LOT; NMR; -; A=1-55.
DR   PDB; 2LOU; NMR; -; A=1-55.
DR   PDB; 2LOV; NMR; -; A=1-55.
DR   PDB; 2LOW; NMR; -; A=1-55.
DR   PDB; 5VBL; X-ray; 2.60 A; B=7-229, B=243-330.
DR   PDB; 6KNM; X-ray; 3.20 A; B=7-229, B=243-330.
DR   PDBsum; 2LOT; -.
DR   PDBsum; 2LOU; -.
DR   PDBsum; 2LOV; -.
DR   PDBsum; 2LOW; -.
DR   PDBsum; 5VBL; -.
DR   PDBsum; 6KNM; -.
DR   BMRB; P35414; -.
DR   SMR; P35414; -.
DR   BioGRID; 106693; 119.
DR   IntAct; P35414; 109.
DR   MINT; P35414; -.
DR   STRING; 9606.ENSP00000475344; -.
DR   BindingDB; P35414; -.
DR   ChEMBL; CHEMBL1628481; -.
DR   GuidetoPHARMACOLOGY; 36; -.
DR   TCDB; 9.A.14.13.10; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; P35414; 2 sites.
DR   iPTMnet; P35414; -.
DR   PhosphoSitePlus; P35414; -.
DR   BioMuta; APLNR; -.
DR   DMDM; 543823; -.
DR   jPOST; P35414; -.
DR   MassIVE; P35414; -.
DR   PaxDb; P35414; -.
DR   PeptideAtlas; P35414; -.
DR   PRIDE; P35414; -.
DR   ProteomicsDB; 55061; -.
DR   ABCD; P35414; 2 sequenced antibodies.
DR   Antibodypedia; 14066; 540 antibodies.
DR   DNASU; 187; -.
DR   Ensembl; ENST00000257254; ENSP00000257254; ENSG00000134817.
DR   Ensembl; ENST00000606794; ENSP00000475344; ENSG00000134817.
DR   Ensembl; ENST00000611099; ENSP00000477818; ENSG00000134817.
DR   GeneID; 187; -.
DR   KEGG; hsa:187; -.
DR   UCSC; uc001njo.4; human.
DR   CTD; 187; -.
DR   DisGeNET; 187; -.
DR   EuPathDB; HostDB:ENSG00000134817.10; -.
DR   GeneCards; APLNR; -.
DR   HGNC; HGNC:339; APLNR.
DR   HPA; ENSG00000134817; Group enriched (brain, lymphoid tissue, placenta).
DR   MIM; 600052; gene.
DR   neXtProt; NX_P35414; -.
DR   OpenTargets; ENSG00000134817; -.
DR   PharmGKB; PA162376687; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01000000214406; -.
DR   HOGENOM; CLU_009579_8_1_1; -.
DR   InParanoid; P35414; -.
DR   KO; K04174; -.
DR   OMA; TVMLTCY; -.
DR   OrthoDB; 788659at2759; -.
DR   PhylomeDB; P35414; -.
DR   TreeFam; TF330024; -.
DR   PathwayCommons; P35414; -.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P35414; -.
DR   BioGRID-ORCS; 187; 4 hits in 873 CRISPR screens.
DR   ChiTaRS; APLNR; human.
DR   GeneWiki; Apelin_receptor; -.
DR   GenomeRNAi; 187; -.
DR   Pharos; P35414; Tchem.
DR   PRO; PR:P35414; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P35414; protein.
DR   Bgee; ENSG00000134817; Expressed in spinal cord and 213 other tissues.
DR   Genevisible; P35414; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0060182; F:apelin receptor activity; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0007512; P:adult heart development; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0001568; P:blood vessel development; IBA:GO_Central.
DR   GO; GO:0060976; P:coronary vasculature development; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007369; P:gastrulation; IEA:UniProtKB-KW.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0043951; P:negative regulation of cAMP-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:1903589; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:1904325; P:positive regulation of inhibitory G protein-coupled receptor phosphorylation; IMP:UniProtKB.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IMP:UniProtKB.
DR   GO; GO:0050878; P:regulation of body fluid levels; IEA:Ensembl.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR003904; APJ_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01416; APJRECEPTOR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Angiogenesis; Cell membrane; Developmental protein;
KW   G-protein coupled receptor; Gastrulation; Glycoprotein;
KW   Host-virus interaction; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..380
FT                   /note="Apelin receptor"
FT                   /id="PRO_0000069173"
FT   TOPO_DOM        1..26
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        27..51
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        52..66
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        67..91
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        92..100
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        101..125
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        126..144
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        145..166
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        167..200
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        201..221
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        222..244
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        245..271
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        272..284
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        285..308
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        309..380
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        15
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        175
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         300
FT                   /note="V -> I (in dbSNP:rs7943508)"
FT                   /id="VAR_049375"
FT   STRAND          9..12
FT                   /evidence="ECO:0000244|PDB:2LOV"
FT   HELIX           13..16
FT                   /evidence="ECO:0000244|PDB:2LOU"
FT   STRAND          18..20
FT                   /evidence="ECO:0000244|PDB:2LOT"
FT   TURN            21..23
FT                   /evidence="ECO:0000244|PDB:2LOT"
FT   HELIX           24..27
FT                   /evidence="ECO:0000244|PDB:2LOT"
FT   HELIX           30..55
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           58..60
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           65..79
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           82..90
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           98..131
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           137..140
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           142..160
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           162..167
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   STRAND          168..171
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   STRAND          174..177
FT                   /evidence="ECO:0000244|PDB:6KNM"
FT   STRAND          180..183
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   TURN            186..188
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   TURN            191..193
FT                   /evidence="ECO:0000244|PDB:6KNM"
FT   HELIX           194..209
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           211..228
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           245..275
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   TURN            276..278
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           281..312
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   HELIX           314..325
FT                   /evidence="ECO:0000244|PDB:5VBL"
FT   TURN            326..329
FT                   /evidence="ECO:0000244|PDB:5VBL"
SQ   SEQUENCE   380 AA;  42660 MW;  78DB18BEA6D2B2E4 CRC64;
     MEEGGDFDNY YGADNQSECE YTDWKSSGAL IPAIYMLVFL LGTTGNGLVL WTVFRSSREK
     RRSADIFIAS LAVADLTFVV TLPLWATYTY RDYDWPFGTF FCKLSSYLIF VNMYASVFCL
     TGLSFDRYLA IVRPVANARL RLRVSGAVAT AVLWVLAALL AMPVMVLRTT GDLENTTKVQ
     CYMDYSMVAT VSSEWAWEVG LGVSSTTVGF VVPFTIMLTC YFFIAQTIAG HFRKERIEGL
     RKRRRLLSII VVLVVTFALC WMPYHLVKTL YMLGSLLHWP CDFDLFLMNI FPYCTCISYV
     NSCLNPFLYA FFDPRFRQAC TSMLCCGQSR CAGTSHSSSG EKSASYSSGH SQGPGPNMGK
     GGEQMHEKSI PYSQETLVVD
//
ID   CCR7_HUMAN              Reviewed;         378 AA.
AC   P32248;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   07-OCT-2020, entry version 188.
DE   RecName: Full=C-C chemokine receptor type 7;
DE            Short=C-C CKR-7;
DE            Short=CC-CKR-7;
DE            Short=CCR-7;
DE   AltName: Full=BLR2;
DE   AltName: Full=CDw197;
DE   AltName: Full=Epstein-Barr virus-induced G-protein coupled receptor 1;
DE            Short=EBI1;
DE            Short=EBV-induced G-protein coupled receptor 1;
DE   AltName: Full=MIP-3 beta receptor;
DE   AltName: CD_antigen=CD197;
DE   Flags: Precursor;
GN   Name=CCR7; Synonyms=CMKBR7, EBI1, EVI1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8383238;
RA   Birkenbach M.P., Josefsen K., Yalamanchili R.R., Lenoir G.M., Kieff E.;
RT   "Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-
RT   coupled peptide receptors.";
RL   J. Virol. 67:2209-2220(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7851893; DOI=10.1006/geno.1994.1553;
RA   Schweickart V.L., Raport C.J., Godiska R., Byers M.G., Eddy R.L. Jr.,
RA   Shows T.B., Gray P.W.;
RT   "Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled
RT   receptor encoded on human chromosome 17q12-q21.2.";
RL   Genomics 23:643-650(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for the MIP-3-beta chemokine. Probable mediator of
CC       EBV effects on B-lymphocytes or of normal lymphocyte functions.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in various lymphoid tissues and activated
CC       B- and T-lymphocytes, strongly up-regulated in B-cells infected with
CC       Epstein-Barr virus and T-cells infected with herpesvirus 6 or 7.
CC   -!- INDUCTION: By Epstein-Barr virus (EBV).
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CC chemokine receptors entry;
CC       URL="https://en.wikipedia.org/wiki/CC_chemokine_receptors";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L08176; AAA58615.1; -; mRNA.
DR   EMBL; L31584; AAA74230.1; -; Genomic_DNA.
DR   EMBL; L31582; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31583; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31581; AAA74231.1; -; mRNA.
DR   EMBL; AY587876; AAT52232.1; -; mRNA.
DR   EMBL; BC035343; AAH35343.1; -; mRNA.
DR   CCDS; CCDS11369.1; -.
DR   PIR; A45680; A45680.
DR   PIR; B55735; B55735.
DR   RefSeq; NP_001288643.1; NM_001301714.1.
DR   RefSeq; NP_001288645.1; NM_001301716.1.
DR   RefSeq; NP_001288646.1; NM_001301717.1.
DR   RefSeq; NP_001288647.1; NM_001301718.1.
DR   RefSeq; NP_001829.1; NM_001838.3.
DR   PDB; 6QZH; X-ray; 2.10 A; A=46-247.
DR   PDBsum; 6QZH; -.
DR   SMR; P32248; -.
DR   BioGRID; 107641; 2.
DR   DIP; DIP-5855N; -.
DR   IntAct; P32248; 4.
DR   MINT; P32248; -.
DR   STRING; 9606.ENSP00000246657; -.
DR   BindingDB; P32248; -.
DR   ChEMBL; CHEMBL4594; -.
DR   GuidetoPHARMACOLOGY; 64; -.
DR   GlyGen; P32248; 1 site.
DR   iPTMnet; P32248; -.
DR   PhosphoSitePlus; P32248; -.
DR   BioMuta; CCR7; -.
DR   DMDM; 1352335; -.
DR   MassIVE; P32248; -.
DR   MaxQB; P32248; -.
DR   PaxDb; P32248; -.
DR   PeptideAtlas; P32248; -.
DR   PRIDE; P32248; -.
DR   ProteomicsDB; 54856; -.
DR   Antibodypedia; 3533; 1041 antibodies.
DR   DNASU; 1236; -.
DR   Ensembl; ENST00000246657; ENSP00000246657; ENSG00000126353.
DR   GeneID; 1236; -.
DR   KEGG; hsa:1236; -.
DR   UCSC; uc002huw.4; human.
DR   CTD; 1236; -.
DR   DisGeNET; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   GeneCards; CCR7; -.
DR   HGNC; HGNC:1608; CCR7.
DR   HPA; ENSG00000126353; Group enriched (blood, lymphoid tissue).
DR   MIM; 600242; gene.
DR   neXtProt; NX_P32248; -.
DR   OpenTargets; ENSG00000126353; -.
DR   PharmGKB; PA26172; -.
DR   eggNOG; ENOG502QUZ9; Eukaryota.
DR   GeneTree; ENSGT00950000182749; -.
DR   InParanoid; P32248; -.
DR   KO; K04182; -.
DR   OMA; TLACFRC; -.
DR   OrthoDB; 715251at2759; -.
DR   PhylomeDB; P32248; -.
DR   TreeFam; TF330966; -.
DR   PathwayCommons; P32248; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P32248; -.
DR   BioGRID-ORCS; 1236; 4 hits in 875 CRISPR screens.
DR   GeneWiki; C-C_chemokine_receptor_type_7; -.
DR   GenomeRNAi; 1236; -.
DR   Pharos; P32248; Tbio.
DR   PRO; PR:P32248; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P32248; protein.
DR   Bgee; ENSG00000126353; Expressed in blood and 136 other tissues.
DR   ExpressionAtlas; P32248; baseline and differential.
DR   Genevisible; P32248; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0019957; F:C-C chemokine binding; IBA:GO_Central.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; ISS:BHF-UCL.
DR   GO; GO:0038117; F:C-C motif chemokine 19 receptor activity; IDA:UniProtKB.
DR   GO; GO:0038121; F:C-C motif chemokine 21 receptor activity; IDA:UniProtKB.
DR   GO; GO:0035757; F:chemokine (C-C motif) ligand 19 binding; IPI:BHF-UCL.
DR   GO; GO:0035758; F:chemokine (C-C motif) ligand 21 binding; IPI:BHF-UCL.
DR   GO; GO:0019956; F:chemokine binding; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; TAS:BHF-UCL.
DR   GO; GO:0090630; P:activation of GTPase activity; IC:BHF-UCL.
DR   GO; GO:0019722; P:calcium-mediated signaling; IBA:GO_Central.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:BHF-UCL.
DR   GO; GO:0006935; P:chemotaxis; IBA:GO_Central.
DR   GO; GO:0002407; P:dendritic cell chemotaxis; IC:BHF-UCL.
DR   GO; GO:0001768; P:establishment of T cell polarity; IC:BHF-UCL.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; NAS:BHF-UCL.
DR   GO; GO:0097022; P:lymphocyte migration into lymph node; TAS:BHF-UCL.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0002408; P:myeloid dendritic cell chemotaxis; IDA:BHF-UCL.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; IC:BHF-UCL.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IC:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IC:BHF-UCL.
DR   GO; GO:2000147; P:positive regulation of cell motility; IC:BHF-UCL.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IC:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IC:BHF-UCL.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0002922; P:positive regulation of humoral immune response; ISS:BHF-UCL.
DR   GO; GO:0002885; P:positive regulation of hypersensitivity; ISS:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IC:BHF-UCL.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IC:BHF-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IC:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IC:BHF-UCL.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000525; P:positive regulation of T cell costimulation; ISS:BHF-UCL.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:2000547; P:regulation of dendritic cell dendrite assembly; ISS:BHF-UCL.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; ISS:BHF-UCL.
DR   GO; GO:0032651; P:regulation of interleukin-1 beta production; ISS:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IC:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071731; P:response to nitric oxide; IC:BHF-UCL.
DR   GO; GO:0034695; P:response to prostaglandin E; IC:BHF-UCL.
DR   GO; GO:0031529; P:ruffle organization; IC:BHF-UCL.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Polymorphism; Receptor; Reference proteome; Signal;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..378
FT                   /note="C-C chemokine receptor type 7"
FT                   /id="PRO_0000012735"
FT   TOPO_DOM        25..59
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..86
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        87..95
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        96..116
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        117..130
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..152
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        153..170
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        171..191
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        192..219
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        220..247
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        248..263
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..289
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..313
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        314..331
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..378
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        129..210
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         7
FT                   /note="M -> V (in dbSNP:rs2228015)"
FT                   /id="VAR_049383"
FT   CONFLICT        182..183
FT                   /note="IW -> SA (in Ref. 1; AAA58615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337
FT                   /note="L -> I (in Ref. 1; AAA58615)"
FT                   /evidence="ECO:0000305"
FT   HELIX           56..84
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           85..89
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           92..108
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           111..119
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           125..157
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           168..171
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           173..190
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           191..195
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   STRAND          196..200
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   STRAND          209..212
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           221..231
FT                   /evidence="ECO:0000244|PDB:6QZH"
FT   HELIX           233..247
FT                   /evidence="ECO:0000244|PDB:6QZH"
SQ   SEQUENCE   378 AA;  42874 MW;  D4CB4213841A1BD4 CRC64;
     MDLGKPMKSV LVVALLVIFQ VCLCQDEVTD DYIGDNTTVD YTLFESLCSK KDVRNFKAWF
     LPIMYSIICF VGLLGNGLVV LTYIYFKRLK TMTDTYLLNL AVADILFLLT LPFWAYSAAK
     SWVFGVHFCK LIFAIYKMSF FSGMLLLLCI SIDRYVAIVQ AVSAHRHRAR VLLISKLSCV
     GIWILATVLS IPELLYSDLQ RSSSEQAMRC SLITEHVEAF ITIQVAQMVI GFLVPLLAMS
     FCYLVIIRTL LQARNFERNK AIKVIIAVVV VFIVFQLPYN GVVLAQTVAN FNITSSTCEL
     SKQLNIAYDV TYSLACVRCC VNPFLYAFIG VKFRNDLFKL FKDLGCLSQE QLRQWSSCRH
     IRRSSMSVEA ETTTTFSP
//
ID   AA2AR_HUMAN             Reviewed;         412 AA.
AC   P29274; B2R7E0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   07-OCT-2020, entry version 215.
DE   RecName: Full=Adenosine receptor A2a;
GN   Name=ADORA2A; Synonyms=ADORA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tiffany H.L., Murphy P.M.;
RL   Submitted (JUL-1992) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Salvatore C.A., Luneau C.J., Johnson R.G., Jacobson M.;
RL   Submitted (SEP-1992) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=1331670; DOI=10.1016/0169-328x(92)90152-2;
RA   Furlong T.J., Pierce K.D., Selbie L.A., Shine J.;
RT   "Molecular characterization of a human brain adenosine A2 receptor.";
RL   Brain Res. Mol. Brain Res. 15:62-66(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8670304; DOI=10.1006/bbrc.1996.0916;
RA   Le F., Townsend-Nicholson A., Baker E., Sutherland G.R., Schofield P.R.;
RT   "Characterization and chromosomal localization of the human A2a adenosine
RT   receptor gene: ADORA2A.";
RL   Biochem. Biophys. Res. Commun. 223:461-467(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   INTERACTION WITH NECAB2.
RX   PubMed=17689978; DOI=10.1016/j.mcn.2007.05.007;
RA   Canela L., Lujan R., Lluis C., Burgueno J., Mallol J., Canela E.I.,
RA   Franco R., Ciruela F.;
RT   "The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the
RT   adenosine A(2A) receptor and modulates the cell surface expression and
RT   function of the receptor.";
RL   Mol. Cell. Neurosci. 36:1-12(2007).
RN   [12]
RP   POSSIBLE INTERACTION WITH DRD4.
RX   PubMed=20836733; DOI=10.3109/10799893.2010.513842;
RA   Woods A.S.;
RT   "The dopamine D(4) receptor, the ultimate disordered protein.";
RL   J. Recept. Signal Transduct. 30:331-336(2010).
RN   [13]
RP   3D-STRUCTURE MODELING OF TRANSMEMBRANE DOMAINS.
RX   PubMed=7775460; DOI=10.1074/jbc.270.23.13987;
RA   Kim J., Wess J., van Rhee A.M., Schoneberg T., Jacobson K.A.;
RT   "Site-directed mutagenesis identifies residues involved in ligand
RT   recognition in the human A2a adenosine receptor.";
RL   J. Biol. Chem. 270:13987-13997(1995).
RN   [14]
RP   INTERACTION WITH USP4, UBIQUITINATION, AND DEUBIQUITINATION BY USP4.
RX   PubMed=16339847; DOI=10.1124/mol.105.015818;
RA   Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M.,
RA   Ducza E., Ogris E., Boehm S., Freissmuth M., Nanoff C.;
RT   "The ubiquitin-specific protease Usp4 regulates the cell surface level of
RT   the A2A receptor.";
RL   Mol. Pharmacol. 69:1083-1094(2006).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 2-316 IN COMPLEX WITH ANTAGONIST,
RP   TOPOLOGY, AND DISULFIDE BONDS.
RX   PubMed=18832607; DOI=10.1126/science.1164772;
RA   Jaakola V.-P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y.T.,
RA   Lane J.R., Ijzerman A.P., Stevens R.C.;
RT   "The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound
RT   to an antagonist.";
RL   Science 322:1211-1217(2008).
RN   [16]
RP   VARIANT VAL-50.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions of
RT   human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [17]
RP   ERRATUM OF PUBMED:10391209.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Receptor for adenosine (By similarity). The activity of this
CC       receptor is mediated by G proteins which activate adenylyl cyclase (By
CC       similarity). {ECO:0000250|UniProtKB:P11617}.
CC   -!- SUBUNIT: Interacts (via cytoplasmic C-terminal domain) with USP4; the
CC       interaction is direct (PubMed:16339847). May interact with DRD4
CC       (PubMed:18832607). Interacts with NECAB2 (PubMed:17689978). Interacts
CC       (via cytoplasmic C-terminal domain) with GAS2L2; interaction enhances
CC       receptor-mediated adenylyl cyclase activity (By similarity).
CC       {ECO:0000250|UniProtKB:P30543, ECO:0000269|PubMed:16339847,
CC       ECO:0000269|PubMed:17689978, ECO:0000269|PubMed:18832607}.
CC   -!- INTERACTION:
CC       P29274; P30542: ADORA1; NbExp=4; IntAct=EBI-2902702, EBI-2903663;
CC       P29274; P29274: ADORA2A; NbExp=8; IntAct=EBI-2902702, EBI-2902702;
CC       P29274; P29275: ADORA2B; NbExp=5; IntAct=EBI-2902702, EBI-3904751;
CC       P29274; O15155: BET1; NbExp=3; IntAct=EBI-2902702, EBI-749204;
CC       P29274; P0DP25: CALM3; NbExp=3; IntAct=EBI-2902702, EBI-397435;
CC       P29274; P21554: CNR1; NbExp=8; IntAct=EBI-2902702, EBI-2909859;
CC       P29274; Q99418: CYTH2; NbExp=6; IntAct=EBI-2902702, EBI-448974;
CC       P29274; P14416: DRD2; NbExp=4; IntAct=EBI-2902702, EBI-2928178;
CC       P29274; O15354: GPR37; NbExp=3; IntAct=EBI-2902702, EBI-15639515;
CC       P29274; Q7Z6G3: NECAB2; NbExp=6; IntAct=EBI-2902702, EBI-950070;
CC       P29274; O43759-2: SYNGR1; NbExp=3; IntAct=EBI-2902702, EBI-12187159;
CC       P29274; Q13107: USP4; NbExp=4; IntAct=EBI-2902702, EBI-723290;
CC       P29274; Q5T9L3-1: WLS; NbExp=3; IntAct=EBI-2902702, EBI-22114623;
CC       P29274; P31424-1: Grm5; Xeno; NbExp=3; IntAct=EBI-2902702, EBI-2902778;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P30543};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P30543}.
CC       Note=Colocalizes with GAS2L2 at neuronal processes.
CC       {ECO:0000250|UniProtKB:P30543}.
CC   -!- DOMAIN: The cytoplasmic C-terminal domain is necessary for targeting
CC       the non-ubiquitinated form of this protein to the cell surface.
CC   -!- PTM: Ubiquitinated. Deubiquitinated by USP4; leading to stabilization
CC       and expression at the cell surface. {ECO:0000269|PubMed:16339847}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58356.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97370; AAA58356.1; ALT_INIT; mRNA.
DR   EMBL; X68486; CAA48504.1; -; mRNA.
DR   EMBL; S46950; AAB23956.1; -; mRNA.
DR   EMBL; U40771; AAA83270.1; -; Genomic_DNA.
DR   EMBL; U40770; AAA83270.1; JOINED; Genomic_DNA.
DR   EMBL; AY136747; AAN01273.1; -; mRNA.
DR   EMBL; CR456367; CAG30253.1; -; mRNA.
DR   EMBL; BT006999; AAP35645.1; -; mRNA.
DR   EMBL; AK312946; BAG35787.1; -; mRNA.
DR   EMBL; CH471095; EAW59658.1; -; Genomic_DNA.
DR   EMBL; BC013780; AAH13780.1; -; mRNA.
DR   CCDS; CCDS13826.1; -.
DR   PIR; A48978; A48978.
DR   RefSeq; NP_000666.2; NM_000675.5.
DR   RefSeq; NP_001265426.1; NM_001278497.1.
DR   RefSeq; NP_001265427.1; NM_001278498.1.
DR   RefSeq; NP_001265428.1; NM_001278499.1.
DR   RefSeq; NP_001265429.1; NM_001278500.1.
DR   PDB; 1MMH; Model; -; 1=6-36, 2=42-69, 3=78-102, 4=117-143, 5=175-203, 6=233-260, 7=264-296.
DR   PDB; 1UPE; Model; -; A=1-304.
DR   PDB; 2YDO; X-ray; 3.00 A; A=1-317.
DR   PDB; 2YDV; X-ray; 2.60 A; A=1-317.
DR   PDB; 3EML; X-ray; 2.60 A; A=2-208, A=222-316.
DR   PDB; 3PWH; X-ray; 3.30 A; A=1-317.
DR   PDB; 3QAK; X-ray; 2.71 A; A=2-208, A=222-316.
DR   PDB; 3REY; X-ray; 3.31 A; A=1-317.
DR   PDB; 3RFM; X-ray; 3.60 A; A=1-317.
DR   PDB; 3UZA; X-ray; 3.27 A; A=1-317.
DR   PDB; 3UZC; X-ray; 3.34 A; A=1-317.
DR   PDB; 3VG9; X-ray; 2.70 A; A=1-316.
DR   PDB; 3VGA; X-ray; 3.10 A; A=1-316.
DR   PDB; 4EIY; X-ray; 1.80 A; A=2-208, A=219-316.
DR   PDB; 4UG2; X-ray; 2.60 A; A/B=1-317.
DR   PDB; 4UHR; X-ray; 2.60 A; A=1-317.
DR   PDB; 5G53; X-ray; 3.40 A; A/B=1-308.
DR   PDB; 5IU4; X-ray; 1.72 A; A=2-208, A=219-318.
DR   PDB; 5IU7; X-ray; 1.90 A; A=2-208, A=219-315.
DR   PDB; 5IU8; X-ray; 2.00 A; A=2-208, A=219-315.
DR   PDB; 5IUA; X-ray; 2.20 A; A=2-208, A=219-315.
DR   PDB; 5IUB; X-ray; 2.10 A; A=2-208, A=219-315.
DR   PDB; 5JTB; X-ray; 2.80 A; A=2-212, A=219-316.
DR   PDB; 5K2A; X-ray; 2.50 A; A=2-208, A=219-316.
DR   PDB; 5K2B; X-ray; 2.50 A; A=2-208, A=219-316.
DR   PDB; 5K2C; X-ray; 1.90 A; A=2-208, A=219-316.
DR   PDB; 5K2D; X-ray; 1.90 A; A=2-208, A=219-316.
DR   PDB; 5MZJ; X-ray; 2.00 A; A=2-208, A=219-318.
DR   PDB; 5MZP; X-ray; 2.10 A; A=2-208, A=219-317.
DR   PDB; 5N2R; X-ray; 2.80 A; A=2-208, A=219-318.
DR   PDB; 5NLX; X-ray; 2.14 A; A=2-317.
DR   PDB; 5NM2; X-ray; 1.95 A; A=2-317.
DR   PDB; 5NM4; X-ray; 1.70 A; A=2-317.
DR   PDB; 5OLG; X-ray; 1.87 A; A=2-208, A=219-317.
DR   PDB; 5OLH; X-ray; 2.60 A; A=2-208, A=219-317.
DR   PDB; 5OLO; X-ray; 3.10 A; A=2-208, A=219-318.
DR   PDB; 5OLV; X-ray; 2.00 A; A=2-208, A=219-317.
DR   PDB; 5OLZ; X-ray; 1.90 A; A=2-208, A=219-317.
DR   PDB; 5OM1; X-ray; 2.10 A; A=2-208, A=219-317.
DR   PDB; 5OM4; X-ray; 2.00 A; A=2-208, A=219-317.
DR   PDB; 5UIG; X-ray; 3.50 A; A=1-191, A=219-316.
DR   PDB; 5UVI; X-ray; 3.20 A; A=2-212, A=219-316.
DR   PDB; 5VRA; X-ray; 2.35 A; A=2-208, A=219-316.
DR   PDB; 5WF5; X-ray; 2.60 A; A=2-208, A=222-316.
DR   PDB; 5WF6; X-ray; 2.90 A; A=2-208, A=222-316.
DR   PDB; 6AQF; X-ray; 2.51 A; A=2-208, A=219-316.
DR   PDB; 6GDG; EM; 4.11 A; A=8-316.
DR   PDB; 6GT3; X-ray; 2.00 A; A=2-208, A=219-317.
DR   PDB; 6JZH; X-ray; 2.25 A; A=2-208, A=219-316.
DR   PDB; 6MH8; X-ray; 4.20 A; A=2-208, A=219-316.
DR   PDB; 6PS7; X-ray; 1.85 A; A=2-208, A=219-316.
DR   PDB; 6S0Q; X-ray; 2.65 A; A=2-208, A=219-317.
DR   PDBsum; 1MMH; -.
DR   PDBsum; 1UPE; -.
DR   PDBsum; 2YDO; -.
DR   PDBsum; 2YDV; -.
DR   PDBsum; 3EML; -.
DR   PDBsum; 3PWH; -.
DR   PDBsum; 3QAK; -.
DR   PDBsum; 3REY; -.
DR   PDBsum; 3RFM; -.
DR   PDBsum; 3UZA; -.
DR   PDBsum; 3UZC; -.
DR   PDBsum; 3VG9; -.
DR   PDBsum; 3VGA; -.
DR   PDBsum; 4EIY; -.
DR   PDBsum; 4UG2; -.
DR   PDBsum; 4UHR; -.
DR   PDBsum; 5G53; -.
DR   PDBsum; 5IU4; -.
DR   PDBsum; 5IU7; -.
DR   PDBsum; 5IU8; -.
DR   PDBsum; 5IUA; -.
DR   PDBsum; 5IUB; -.
DR   PDBsum; 5JTB; -.
DR   PDBsum; 5K2A; -.
DR   PDBsum; 5K2B; -.
DR   PDBsum; 5K2C; -.
DR   PDBsum; 5K2D; -.
DR   PDBsum; 5MZJ; -.
DR   PDBsum; 5MZP; -.
DR   PDBsum; 5N2R; -.
DR   PDBsum; 5NLX; -.
DR   PDBsum; 5NM2; -.
DR   PDBsum; 5NM4; -.
DR   PDBsum; 5OLG; -.
DR   PDBsum; 5OLH; -.
DR   PDBsum; 5OLO; -.
DR   PDBsum; 5OLV; -.
DR   PDBsum; 5OLZ; -.
DR   PDBsum; 5OM1; -.
DR   PDBsum; 5OM4; -.
DR   PDBsum; 5UIG; -.
DR   PDBsum; 5UVI; -.
DR   PDBsum; 5VRA; -.
DR   PDBsum; 5WF5; -.
DR   PDBsum; 5WF6; -.
DR   PDBsum; 6AQF; -.
DR   PDBsum; 6GDG; -.
DR   PDBsum; 6GT3; -.
DR   PDBsum; 6JZH; -.
DR   PDBsum; 6MH8; -.
DR   PDBsum; 6PS7; -.
DR   PDBsum; 6S0Q; -.
DR   SMR; P29274; -.
DR   BioGRID; 106647; 14.
DR   IntAct; P29274; 23.
DR   MINT; P29274; -.
DR   STRING; 9606.ENSP00000480012; -.
DR   BindingDB; P29274; -.
DR   ChEMBL; CHEMBL251; -.
DR   DrugBank; DB08770; 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol.
DR   DrugBank; DB14132; 8-chlorotheophylline.
DR   DrugBank; DB00640; Adenosine.
DR   DrugBank; DB05009; Apadenoson.
DR   DrugBank; DB05191; Atl146e.
DR   DrugBank; DB04853; Binodenoson.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB04932; Defibrotide.
DR   DrugBank; DB09273; Doxofylline.
DR   DrugBank; DB00651; Dyphylline.
DR   DrugBank; DB00824; Enprofylline.
DR   DrugBank; DB11757; Istradefylline.
DR   DrugBank; DB00555; Lamotrigine.
DR   DrugBank; DB00358; Mefloquine.
DR   DrugBank; DB01303; Oxtriphylline.
DR   DrugBank; DB00806; Pentoxifylline.
DR   DrugBank; DB06213; Regadenoson.
DR   DrugBank; DB01412; Theobromine.
DR   DrugBank; DB00277; Theophylline.
DR   DrugCentral; P29274; -.
DR   GuidetoPHARMACOLOGY; 19; -.
DR   TCDB; 9.A.14.3.8; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; P29274; 1 site.
DR   iPTMnet; P29274; -.
DR   PhosphoSitePlus; P29274; -.
DR   BioMuta; ADORA2A; -.
DR   DMDM; 543740; -.
DR   MassIVE; P29274; -.
DR   PaxDb; P29274; -.
DR   PeptideAtlas; P29274; -.
DR   PRIDE; P29274; -.
DR   ProteomicsDB; 54531; -.
DR   ABCD; P29274; 3 sequenced antibodies.
DR   Antibodypedia; 9718; 410 antibodies.
DR   DNASU; 135; -.
DR   Ensembl; ENST00000337539; ENSP00000336630; ENSG00000128271.
DR   Ensembl; ENST00000610595; ENSP00000480012; ENSG00000128271.
DR   Ensembl; ENST00000611543; ENSP00000483102; ENSG00000128271.
DR   Ensembl; ENST00000618076; ENSP00000481552; ENSG00000128271.
DR   GeneID; 135; -.
DR   KEGG; hsa:135; -.
DR   CTD; 135; -.
DR   DisGeNET; 135; -.
DR   EuPathDB; HostDB:ENSG00000128271.20; -.
DR   EuPathDB; HostDB:ENSG00000258555.5; -.
DR   GeneCards; ADORA2A; -.
DR   HGNC; HGNC:263; ADORA2A.
DR   HPA; ENSG00000128271; Group enriched (blood, bone marrow, brain, lymphoid tissue).
DR   MalaCards; ADORA2A; -.
DR   MIM; 102776; gene.
DR   neXtProt; NX_P29274; -.
DR   OpenTargets; ENSG00000128271; -.
DR   Orphanet; 363549; Acute encephalopathy with biphasic seizures and late reduced diffusion.
DR   PharmGKB; PA24584; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT00990000203617; -.
DR   InParanoid; P29274; -.
DR   KO; K04266; -.
DR   OMA; IHRDPEK; -.
DR   OrthoDB; 550297at2759; -.
DR   TreeFam; TF325296; -.
DR   PathwayCommons; P29274; -.
DR   Reactome; R-HSA-187024; NGF-independant TRKA activation.
DR   Reactome; R-HSA-417973; Adenosine P1 receptors.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SIGNOR; P29274; -.
DR   BioGRID-ORCS; 135; 7 hits in 872 CRISPR screens.
DR   EvolutionaryTrace; P29274; -.
DR   GeneWiki; Adenosine_A2A_receptor; -.
DR   GenomeRNAi; 135; -.
DR   Pharos; P29274; Tclin.
DR   PRO; PR:P29274; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P29274; protein.
DR   Bgee; ENSG00000128271; Expressed in cerebellum and 114 other tissues.
DR   ExpressionAtlas; P29274; baseline and differential.
DR   Genevisible; P29274; HS.
DR   GO; GO:0030673; C:axolemma; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005882; C:intermediate filament; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0048786; C:presynaptic active zone; IEA:Ensembl.
DR   GO; GO:0051393; F:alpha-actinin binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0001609; F:G protein-coupled adenosine receptor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0031802; F:type 5 metabotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0048143; P:astrocyte activation; IEA:Ensembl.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006968; P:cellular defense response; TAS:ProtInc.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0042755; P:eating behavior; IEA:Ensembl.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0060080; P:inhibitory postsynaptic potential; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Ensembl.
DR   GO; GO:0046636; P:negative regulation of alpha-beta T cell activation; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0040013; P:negative regulation of locomotion; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IEA:Ensembl.
DR   GO; GO:0006909; P:phagocytosis; TAS:ProtInc.
DR   GO; GO:0014057; P:positive regulation of acetylcholine secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0045938; P:positive regulation of circadian sleep/wake cycle, sleep; IEA:Ensembl.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IEA:Ensembl.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0035810; P:positive regulation of urine volume; IEA:Ensembl.
DR   GO; GO:0060134; P:prepulse inhibition; IEA:Ensembl.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; IEA:Ensembl.
DR   GO; GO:0014061; P:regulation of norepinephrine secretion; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0007600; P:sensory perception; TAS:ProtInc.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; IEA:Ensembl.
DR   GO; GO:0001963; P:synaptic transmission, dopaminergic; IEA:Ensembl.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0042311; P:vasodilation; IEA:Ensembl.
DR   DisProt; DP01547; -.
DR   InterPro; IPR001513; Adeno_A2A_rcpt.
DR   InterPro; IPR001634; Adenosn_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00553; ADENOSINA2AR.
DR   PRINTS; PR00424; ADENOSINER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..412
FT                   /note="Adenosine receptor A2a"
FT                   /id="PRO_0000068999"
FT   TOPO_DOM        1..7
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        8..32
FT                   /note="Helical; Name=1"
FT   TOPO_DOM        33..42
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        43..66
FT                   /note="Helical; Name=2"
FT   TOPO_DOM        67..77
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        78..100
FT                   /note="Helical; Name=3"
FT   TOPO_DOM        101..120
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        121..143
FT                   /note="Helical; Name=4"
FT   TOPO_DOM        144..173
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        174..198
FT                   /note="Helical; Name=5"
FT   TOPO_DOM        199..234
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        235..258
FT                   /note="Helical; Name=6"
FT   TOPO_DOM        259..266
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   TRANSMEM        267..290
FT                   /note="Helical; Name=7"
FT   TOPO_DOM        291..412
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18832607"
FT   REGION          168..177
FT                   /note="Agonist binding"
FT   REGION          246..253
FT                   /note="Agonist binding"
FT   REGION          264..274
FT                   /note="Agonist binding"
FT   CARBOHYD        154
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        71..159
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:18832607"
FT   DISULFID        74..146
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:18832607"
FT   DISULFID        77..166
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:18832607"
FT   DISULFID        259..262
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:18832607"
FT   VARIANT         50
FT                   /note="A -> V (in dbSNP:rs4530)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_011835"
FT   VARIANT         300
FT                   /note="R -> H (in dbSNP:rs4990)"
FT                   /id="VAR_011836"
FT   VARIANT         392
FT                   /note="G -> R (in dbSNP:rs1277013918)"
FT                   /id="VAR_003451"
FT   HELIX           2..33
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           35..37
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           40..57
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           59..67
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   STRAND          71..73
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           74..107
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           109..115
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           118..136
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           138..141
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   STRAND          144..148
FT                   /evidence="ECO:0000244|PDB:5JTB"
FT   HELIX           151..157
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   STRAND          163..165
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           168..171
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           174..179
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           182..185
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           187..208
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   STRAND          213..216
FT                   /evidence="ECO:0000244|PDB:3VGA"
FT   HELIX           219..258
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   STRAND          260..262
FT                   /evidence="ECO:0000244|PDB:2YDV"
FT   HELIX           267..291
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   HELIX           293..303
FT                   /evidence="ECO:0000244|PDB:5NM4"
FT   TURN            304..307
FT                   /evidence="ECO:0000244|PDB:3QAK"
FT   TURN            308..310
FT                   /evidence="ECO:0000244|PDB:2YDV"
FT   HELIX           312..317
FT                   /evidence="ECO:0000244|PDB:2YDV"
SQ   SEQUENCE   412 AA;  44707 MW;  9438E9D64A6BE61B CRC64;
     MPIMGSSVYI TVELAIAVLA ILGNVLVCWA VWLNSNLQNV TNYFVVSLAA ADIAVGVLAI
     PFAITISTGF CAACHGCLFI ACFVLVLTQS SIFSLLAIAI DRYIAIRIPL RYNGLVTGTR
     AKGIIAICWV LSFAIGLTPM LGWNNCGQPK EGKNHSQGCG EGQVACLFED VVPMNYMVYF
     NFFACVLVPL LLMLGVYLRI FLAARRQLKQ MESQPLPGER ARSTLQKEVH AAKSLAIIVG
     LFALCWLPLH IINCFTFFCP DCSHAPLWLM YLAIVLSHTN SVVNPFIYAY RIREFRQTFR
     KIIRSHVLRQ QEPFKAAGTS ARVLAAHGSD GEQVSLRLNG HPPGVWANGS APHPERRPNG
     YALGLVSGGS AQESQGNTGL PDVELLSHEL KGVCPEPPGL DDPLAQDGAG VS
//
ID   P2RY4_HUMAN             Reviewed;         365 AA.
AC   P51582; Q4VBB7; Q4VBB8; Q502W2; Q5JT22;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-OCT-2020, entry version 169.
DE   RecName: Full=P2Y purinoceptor 4;
DE            Short=P2Y4;
DE   AltName: Full=P2P;
DE   AltName: Full=Uridine nucleotide receptor;
DE            Short=UNR;
GN   Name=P2RY4; Synonyms=NRU;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8537336; DOI=10.1074/jbc.270.52.30849;
RA   Communi D., Pirotton S., Parmentier M., Boeynaems J.-M.;
RT   "Cloning and functional expression of a human uridine nucleotide
RT   receptor.";
RL   J. Biol. Chem. 270:30849-30852(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-178 AND ALA-234.
RX   PubMed=8537335; DOI=10.1074/jbc.270.52.30845;
RA   Nguyen T., Erb L., Weisman G.A., Marchese A., Heng H.H.Q., Garrad R.C.,
RA   George S.R., Turner J.T., O'Dowd B.F.;
RT   "Cloning, expression, and chromosomal localization of the human uridine
RT   nucleotide receptor gene.";
RL   J. Biol. Chem. 270:30845-30848(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Pancreas;
RX   PubMed=8617367; DOI=10.1016/0014-5793(96)00321-3;
RA   Stam N.J., Klomp J., van der Heuvel M., Olijve W.;
RT   "Molecular cloning and characterization of a novel orphan receptor (P2P)
RT   expressed in human pancreas that shows high structural homology to the P2U
RT   purinoceptor.";
RL   FEBS Lett. 384:260-264(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-178.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-333 AND SER-334, AND MUTAGENESIS OF SER-243;
RP   SER-333; SER-334 AND SER-339.
RX   PubMed=11114308; DOI=10.1074/jbc.m009909200;
RA   Brinson A.E., Harden T.K.;
RT   "Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6
RT   receptors. Ser-333 and Ser-334 in the carboxyl terminus are involved in
RT   agonist-dependent phosphorylation desensitization and internalization of
RT   the P2Y4 receptor.";
RL   J. Biol. Chem. 276:11939-11948(2001).
CC   -!- FUNCTION: Receptor for UTP and UDP coupled to G-proteins that activate
CC       a phosphatidylinositol-calcium second messenger system. Not activated
CC       by ATP or ADP.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Pancreas.
CC   -!- PTM: Phosphorylation of Ser-333 and Ser-334 is a key step in agonist-
CC       dependent desensitization and loss of surface P2RY4. This
CC       phosphorylation does not involve PKC, nor other calcium activated
CC       kinases. {ECO:0000269|PubMed:11114308}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X91852; CAA62963.1; -; Genomic_DNA.
DR   EMBL; U40223; AAC50347.1; -; Genomic_DNA.
DR   EMBL; X96597; CAA65415.1; -; Genomic_DNA.
DR   EMBL; AL357752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC095503; AAH95503.1; -; mRNA.
DR   EMBL; BC096067; AAH96067.1; -; mRNA.
DR   EMBL; BC096068; AAH96068.1; -; mRNA.
DR   EMBL; BC096069; AAH96069.1; -; mRNA.
DR   EMBL; BC096070; AAH96070.1; -; mRNA.
DR   CCDS; CCDS14398.1; -.
DR   PIR; S68679; S68679.
DR   RefSeq; NP_002556.1; NM_002565.3.
DR   PDB; 2B6Q; Model; -; A=1-365.
DR   PDBsum; 2B6Q; -.
DR   IntAct; P51582; 1.
DR   STRING; 9606.ENSP00000363643; -.
DR   BindingDB; P51582; -.
DR   ChEMBL; CHEMBL2123; -.
DR   DrugBank; DB01069; Promethazine.
DR   DrugCentral; P51582; -.
DR   GuidetoPHARMACOLOGY; 325; -.
DR   iPTMnet; P51582; -.
DR   PhosphoSitePlus; P51582; -.
DR   BioMuta; P2RY4; -.
DR   DMDM; 1709524; -.
DR   PaxDb; P51582; -.
DR   PeptideAtlas; P51582; -.
DR   PRIDE; P51582; -.
DR   ProteomicsDB; 56339; -.
DR   Antibodypedia; 13260; 274 antibodies.
DR   Ensembl; ENST00000374519; ENSP00000363643; ENSG00000186912.
DR   GeneID; 5030; -.
DR   KEGG; hsa:5030; -.
DR   UCSC; uc004dxz.2; human.
DR   CTD; 5030; -.
DR   DisGeNET; 5030; -.
DR   EuPathDB; HostDB:ENSG00000186912.6; -.
DR   GeneCards; P2RY4; -.
DR   HGNC; HGNC:8542; P2RY4.
DR   HPA; ENSG00000186912; Tissue enriched (intestine).
DR   MIM; 300038; gene.
DR   neXtProt; NX_P51582; -.
DR   OpenTargets; ENSG00000186912; -.
DR   PharmGKB; PA32871; -.
DR   eggNOG; ENOG502QSTF; Eukaryota.
DR   GeneTree; ENSGT00960000186584; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; P51582; -.
DR   KO; K04271; -.
DR   OMA; TLCHDTT; -.
DR   OrthoDB; 1077455at2759; -.
DR   PhylomeDB; P51582; -.
DR   TreeFam; TF350009; -.
DR   PathwayCommons; P51582; -.
DR   Reactome; R-HSA-417957; P2Y receptors.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P51582; -.
DR   BioGRID-ORCS; 5030; 3 hits in 493 CRISPR screens.
DR   GeneWiki; P2RY4; -.
DR   GenomeRNAi; 5030; -.
DR   Pharos; P51582; Tchem.
DR   PRO; PR:P51582; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; P51582; protein.
DR   Bgee; ENSG00000186912; Expressed in small intestine and 41 other tissues.
DR   Genevisible; P51582; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0045028; F:G protein-coupled purinergic nucleotide receptor activity; IEA:InterPro.
DR   GO; GO:0045030; F:G protein-coupled UTP receptor activity; TAS:GO_Central.
DR   GO; GO:0071318; P:cellular response to ATP; TAS:ARUK-UCL.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc.
DR   GO; GO:0030321; P:transepithelial chloride transport; IEA:Ensembl.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000018; P2Y4.
DR   PANTHER; PTHR24231:SF21; PTHR24231:SF21; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01066; P2Y4PRNOCPTR.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..365
FT                   /note="P2Y purinoceptor 4"
FT                   /id="PRO_0000070020"
FT   TOPO_DOM        1..34
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        35..61
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        62..72
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        73..95
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        96..112
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        113..131
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        132..154
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        155..174
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        175..196
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        197..222
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        223..246
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        247..269
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        270..287
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        288..309
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        310..365
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:11114308"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000305|PubMed:11114308"
FT   DISULFID        108..185
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         168
FT                   /note="V -> M (in dbSNP:rs1152186)"
FT                   /id="VAR_011854"
FT   VARIANT         178
FT                   /note="N -> T (in dbSNP:rs1152187)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:8537335"
FT                   /id="VAR_011855"
FT   VARIANT         191
FT                   /note="P -> L (in dbSNP:rs1152188)"
FT                   /id="VAR_011856"
FT   VARIANT         234
FT                   /note="S -> A (in dbSNP:rs3829709)"
FT                   /evidence="ECO:0000269|PubMed:8537335"
FT                   /id="VAR_049429"
FT   MUTAGEN         243
FT                   /note="S->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:11114308"
FT   MUTAGEN         333..365
FT                   /note="Missing: Abolishes agonist-induced phosphorylation.
FT                   Prevents agonist-induced desensitization and loss of cell
FT                   surface receptors."
FT   MUTAGEN         333..359
FT                   /note="SSLALVSLPEDSSCRWAATPQDSSCST->AALALVALPEDAACRWAAAPQDA
FT                   ACAA: Greatly reduces agonist-induced desensitization and
FT                   loss of cell surface receptors."
FT   MUTAGEN         333
FT                   /note="S->A: Greatly reduces agonist-induced
FT                   desensitization and loss of cell surface receptors; when
FT                   associated with A-334 and A-339."
FT                   /evidence="ECO:0000269|PubMed:11114308"
FT   MUTAGEN         334
FT                   /note="S->A: Greatly reduces agonist-induced
FT                   desensitization and loss of cell surface receptors; when
FT                   associated with A-333 and A-339."
FT                   /evidence="ECO:0000269|PubMed:11114308"
FT   MUTAGEN         339
FT                   /note="S->A: Greatly reduces agonist-induced
FT                   desensitization and loss of cell surface receptors; when
FT                   associated with A-333 and A-334."
FT                   /evidence="ECO:0000269|PubMed:11114308"
FT   MUTAGEN         344..365
FT                   /note="Missing: No effect on agonist-induced
FT                   phosphorylation, no functional effect."
FT   MUTAGEN         356..365
FT                   /note="Missing: No functional effect."
FT   CONFLICT        86
FT                   /note="L -> V (in Ref. 2; AAC50347)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="C -> S (in Ref. 5; AAH96068)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="I -> V (in Ref. 5; AAH96069)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        352
FT                   /note="P -> T (in Ref. 5; AAH96069)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   365 AA;  40963 MW;  23E0AFED3B7BDEED CRC64;
     MASTESSLLR SLGLSPGPGS SEVELDCWFD EDFKFILLPV SYAVVFVLGL GLNAPTLWLF
     IFRLRPWDAT ATYMFHLALS DTLYVLSLPT LIYYYAAHNH WPFGTEICKF VRFLFYWNLY
     CSVLFLTCIS VHRYLGICHP LRALRWGRPR LAGLLCLAVW LVVAGCLVPN LFFVTTSNKG
     TTVLCHDTTR PEEFDHYVHF SSAVMGLLFG VPCLVTLVCY GLMARRLYQP LPGSAQSSSR
     LRSLRTIAVV LTVFAVCFVP FHITRTIYYL ARLLEADCRV LNIVNVVYKV TRPLASANSC
     LDPVLYLLTG DKYRRQLRQL CGGGKPQPRT AASSLALVSL PEDSSCRWAA TPQDSSCSTP
     RADRL
//
ID   S1PR1_HUMAN             Reviewed;         382 AA.
AC   P21453; D3DT66; Q9BYY4; Q9NYN8;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   07-OCT-2020, entry version 200.
DE   RecName: Full=Sphingosine 1-phosphate receptor 1;
DE            Short=S1P receptor 1;
DE            Short=S1P1;
DE   AltName: Full=Endothelial differentiation G-protein coupled receptor 1;
DE   AltName: Full=Sphingosine 1-phosphate receptor Edg-1;
DE            Short=S1P receptor Edg-1;
DE   AltName: CD_antigen=CD363;
GN   Name=S1PR1; Synonyms=CHEDG1, EDG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=2160972;
RA   Hla T., Maciag T.;
RT   "An abundant transcript induced in differentiating human endothelial cells
RT   encodes a polypeptide with structural similarities to G-protein-coupled
RT   receptors.";
RL   J. Biol. Chem. 265:9308-9313(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=9409733; DOI=10.1016/s0014-5793(97)01301-x;
RA   An S., Bleu T., Huang W., Hallmark O.G., Coughlin S.R., Goetzl E.J.;
RT   "Identification of cDNAs encoding two G protein-coupled receptors for
RT   lysosphingolipids.";
RL   FEBS Lett. 417:279-282(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF ARG-120; GLU-121 AND ARG-292.
RX   PubMed=10982820; DOI=10.1074/jbc.m007680200;
RA   Parrill A.L., Wang D., Bautista D.L., Van Brocklyn J.R., Lorincz Z.,
RA   Fischer D.J., Baker D.L., Liliom K., Spiegel S., Tigyi G.;
RT   "Identification of Edg1 receptor residues that recognize sphingosine 1-
RT   phosphate.";
RL   J. Biol. Chem. 275:39379-39384(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Substantia nigra;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH GNAI1 AND GNAI3.
RX   PubMed=8626678; DOI=10.1074/jbc.271.19.11272;
RA   Lee M.-J., Evans M., Hla T.;
RT   "The inducible G protein-coupled receptor edg-1 signals via the
RT   G(i)/mitogen-activated protein kinase pathway.";
RL   J. Biol. Chem. 271:11272-11279(1996).
RN   [10]
RP   FUNCTION.
RX   PubMed=9488656; DOI=10.1126/science.279.5356.1552;
RA   Lee M.-J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R.,
RA   Menzeleev R., Spiegel S., Hla T.;
RT   "Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor
RT   EDG-1.";
RL   Science 279:1552-1555(1998).
RN   [11]
RP   PHARMACOLOGICAL CHARACTERIZATION.
RX   PubMed=10383399; DOI=10.1074/jbc.274.27.18997;
RA   Ancellin N., Hla T.;
RT   "Differential pharmacological properties and signal transduction of the
RT   sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5.";
RL   J. Biol. Chem. 274:18997-19002(1999).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11604399; DOI=10.1074/jbc.m107301200;
RA   Wang D.A., Lorincz Z., Bautista D.L., Liliom K., Tigyi G., Parrill A.L.;
RT   "A single amino acid determines lysophospholipid specificity of the S1P1
RT   (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.";
RL   J. Biol. Chem. 276:49213-49220(2001).
RN   [13]
RP   FUNCTION IN CHEMOTAXIS, PHOSPHORYLATION AT THR-236, AND MUTAGENESIS OF
RP   THR-236.
RX   PubMed=11583630; DOI=10.1016/s1097-2765(01)00324-0;
RA   Lee M.-J., Thangada S., Paik J.-H., Sapkota G.P., Ancellin N., Chae S.-S.,
RA   Wu M., Morales-Ruiz M., Sessa W.C., Alessi D.R., Hla T.;
RT   "Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is
RT   required for endothelial cell chemotaxis.";
RL   Mol. Cell 8:693-704(2001).
RN   [14]
RP   FUNCTION.
RX   PubMed=11230698; DOI=10.1126/science.1057559;
RA   Hobson J.P., Rosenfeldt H.M., Barak L.S., Olivera A., Poulton S.,
RA   Caron M.G., Milstien S., Spiegel S.;
RT   "Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell
RT   motility.";
RL   Science 291:1800-1803(2001).
RN   [15]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND GLYCOSYLATION AT ASN-30.
RX   PubMed=15750791; DOI=10.1007/s10719-004-5540-8;
RA   Kohno T., Igarashi Y.;
RT   "Roles for N-glycosylation in the dynamics of Edg-1/S1P1 in sphingosine 1-
RT   phosphate-stimulated cells.";
RL   Glycoconj. J. 21:497-501(2004).
RN   [16]
RP   FUNCTION, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=19286607; DOI=10.1161/circresaha.108.193367;
RA   Singleton P.A., Chatchavalvanich S., Fu P., Xing J., Birukova A.A.,
RA   Fortune J.A., Klibanov A.M., Garcia J.G., Birukov K.G.;
RT   "Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched
RT   microdomains regulates endothelial barrier enhancement by oxidized
RT   phospholipids.";
RL   Circ. Res. 104:978-986(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-326 IN COMPLEX WITH SPHINGOLIPID
RP   ANALOG, FUNCTION, SUBCELLULAR LOCATION, MEMBRANE TOPOLOGY, MUTAGENESIS OF
RP   PHE-210; PHE-265 AND TRP-269, GLYCOSYLATION AT ASN-30, AND DISULFIDE BONDS.
RX   PubMed=22344443; DOI=10.1126/science.1215904;
RA   Hanson M.A., Roth C.B., Jo E., Griffith M.T., Scott F.L., Reinhart G.,
RA   Desale H., Clemons B., Cahalan S.M., Schuerer S.C., Sanna M.G., Han G.W.,
RA   Kuhn P., Rosen H., Stevens R.C.;
RT   "Crystal structure of a lipid G protein-coupled receptor.";
RL   Science 335:851-855(2012).
CC   -!- FUNCTION: G-protein coupled receptor for the bioactive lysosphingolipid
CC       sphingosine 1-phosphate (S1P) that seems to be coupled to the G(i)
CC       subclass of heteromeric G proteins. Signaling leads to the activation
CC       of RAC1, SRC, PTK2/FAK1 and MAP kinases. Plays an important role in
CC       cell migration, probably via its role in the reorganization of the
CC       actin cytoskeleton and the formation of lamellipodia in response to
CC       stimuli that increase the activity of the sphingosine kinase SPHK1.
CC       Required for normal chemotaxis toward sphingosine 1-phosphate. Required
CC       for normal embryonic heart development and normal cardiac
CC       morphogenesis. Plays an important role in the regulation of sprouting
CC       angiogenesis and vascular maturation. Inhibits sprouting angiogenesis
CC       to prevent excessive sprouting during blood vessel development.
CC       Required for normal egress of mature T-cells from the thymus into the
CC       blood stream and into peripheral lymphoid organs. Plays a role in the
CC       migration of osteoclast precursor cells, the regulation of bone
CC       mineralization and bone homeostasis (By similarity). Plays a role in
CC       responses to oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-
CC       phosphocholine by pulmonary endothelial cells and in the protection
CC       against ventilator-induced lung injury. {ECO:0000250,
CC       ECO:0000269|PubMed:10982820, ECO:0000269|PubMed:11230698,
CC       ECO:0000269|PubMed:11583630, ECO:0000269|PubMed:11604399,
CC       ECO:0000269|PubMed:19286607, ECO:0000269|PubMed:22344443,
CC       ECO:0000269|PubMed:8626678, ECO:0000269|PubMed:9488656}.
CC   -!- SUBUNIT: Interacts with GNAI1 and GNAI3. {ECO:0000269|PubMed:22344443,
CC       ECO:0000269|PubMed:8626678}.
CC   -!- INTERACTION:
CC       P21453; Q07108: CD69; NbExp=2; IntAct=EBI-2681920, EBI-2836595;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Endosome. Membrane raft. Note=Recruited to caveolin-enriched plasma
CC       membrane microdomains in response to oxidized 1-palmitoyl-2-
CC       arachidonoyl-sn-glycero-3-phosphocholine. Ligand binding leads to
CC       receptor internalization.
CC   -!- TISSUE SPECIFICITY: Endothelial cells, and to a lesser extent, in
CC       vascular smooth muscle cells, fibroblasts, melanocytes, and cells of
CC       epithelioid origin.
CC   -!- INDUCTION: By the tumor promoter phorbol 12-myristate 13-acetate (PMA)
CC       in the presence of cycloheximide.
CC   -!- PTM: S1P-induced endothelial cell migration requires the PKB/AKT1-
CC       mediated phosphorylation of the third intracellular loop at the Thr-236
CC       residue. {ECO:0000269|PubMed:11583630, ECO:0000269|PubMed:19286607}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M31210; AAA52336.1; -; mRNA.
DR   EMBL; AF022137; AAC51905.1; -; mRNA.
DR   EMBL; AF233365; AAF43420.1; -; mRNA.
DR   EMBL; AK312493; BAG35395.1; -; mRNA.
DR   EMBL; CR541786; CAG46585.1; -; mRNA.
DR   EMBL; CR542269; CAG47065.1; -; mRNA.
DR   EMBL; AL109741; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW72927.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72928.1; -; Genomic_DNA.
DR   EMBL; BC018650; AAH18650.1; -; mRNA.
DR   CCDS; CCDS777.1; -.
DR   PIR; A35300; A35300.
DR   RefSeq; NP_001307659.1; NM_001320730.1.
DR   RefSeq; NP_001391.2; NM_001400.4.
DR   PDB; 3V2W; X-ray; 3.35 A; A=2-231, A=244-326.
DR   PDB; 3V2Y; X-ray; 2.80 A; A=2-231, A=244-326.
DR   PDBsum; 3V2W; -.
DR   PDBsum; 3V2Y; -.
DR   SMR; P21453; -.
DR   BioGRID; 108225; 30.
DR   CORUM; P21453; -.
DR   DIP; DIP-60427N; -.
DR   IntAct; P21453; 23.
DR   STRING; 9606.ENSP00000305416; -.
DR   BindingDB; P21453; -.
DR   ChEMBL; CHEMBL4333; -.
DR   DrugBank; DB09105; Asfotase alfa.
DR   DrugBank; DB08868; Fingolimod.
DR   DrugBank; DB12612; Ozanimod.
DR   DrugBank; DB12371; Siponimod.
DR   DrugCentral; P21453; -.
DR   GuidetoPHARMACOLOGY; 275; -.
DR   TCDB; 9.A.14.2.1; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; P21453; 2 sites.
DR   iPTMnet; P21453; -.
DR   PhosphoSitePlus; P21453; -.
DR   SwissPalm; P21453; -.
DR   BioMuta; S1PR1; -.
DR   DMDM; 205371820; -.
DR   EPD; P21453; -.
DR   jPOST; P21453; -.
DR   MassIVE; P21453; -.
DR   PaxDb; P21453; -.
DR   PeptideAtlas; P21453; -.
DR   PRIDE; P21453; -.
DR   ProteomicsDB; 53871; -.
DR   Antibodypedia; 4111; 731 antibodies.
DR   DNASU; 1901; -.
DR   Ensembl; ENST00000305352; ENSP00000305416; ENSG00000170989.
DR   Ensembl; ENST00000475289; ENSP00000498038; ENSG00000170989.
DR   Ensembl; ENST00000648480; ENSP00000497478; ENSG00000170989.
DR   Ensembl; ENST00000649383; ENSP00000497175; ENSG00000170989.
DR   GeneID; 1901; -.
DR   KEGG; hsa:1901; -.
DR   UCSC; uc001dud.3; human.
DR   CTD; 1901; -.
DR   DisGeNET; 1901; -.
DR   EuPathDB; HostDB:ENSG00000170989.8; -.
DR   GeneCards; S1PR1; -.
DR   HGNC; HGNC:3165; S1PR1.
DR   HPA; ENSG00000170989; Tissue enhanced (blood).
DR   MIM; 601974; gene.
DR   neXtProt; NX_P21453; -.
DR   OpenTargets; ENSG00000170989; -.
DR   PharmGKB; PA162402344; -.
DR   eggNOG; ENOG502QSFG; Eukaryota.
DR   GeneTree; ENSGT00970000193365; -.
DR   HOGENOM; CLU_047979_1_0_1; -.
DR   InParanoid; P21453; -.
DR   KO; K04288; -.
DR   OMA; CFIACWA; -.
DR   OrthoDB; 981486at2759; -.
DR   PhylomeDB; P21453; -.
DR   TreeFam; TF330052; -.
DR   PathwayCommons; P21453; -.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-419408; Lysosphingolipid and LPA receptors.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   SignaLink; P21453; -.
DR   SIGNOR; P21453; -.
DR   BioGRID-ORCS; 1901; 4 hits in 873 CRISPR screens.
DR   ChiTaRS; S1PR1; human.
DR   GeneWiki; S1PR1; -.
DR   GenomeRNAi; 1901; -.
DR   Pharos; P21453; Tclin.
DR   PRO; PR:P21453; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P21453; protein.
DR   Bgee; ENSG00000170989; Expressed in right lung and 200 other tissues.
DR   ExpressionAtlas; P21453; baseline and differential.
DR   Genevisible; P21453; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IPI:UniProtKB.
DR   GO; GO:0046625; F:sphingolipid binding; IEA:Ensembl.
DR   GO; GO:0038036; F:sphingosine-1-phosphate receptor activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IBA:GO_Central.
DR   GO; GO:0001955; P:blood vessel maturation; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0003245; P:cardiac muscle tissue growth involved in heart morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0006935; P:chemotaxis; ISS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030032; P:lamellipodium assembly; ISS:UniProtKB.
DR   GO; GO:0030595; P:leukocyte chemotaxis; IEA:Ensembl.
DR   GO; GO:0051497; P:negative regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0051482; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0030500; P:regulation of bone mineralization; ISS:UniProtKB.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0019222; P:regulation of metabolic process; IBA:GO_Central.
DR   GO; GO:0003376; P:sphingosine-1-phosphate receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0072678; P:T cell migration; ISS:UniProtKB.
DR   GO; GO:0019226; P:transmission of nerve impulse; IEA:Ensembl.
DR   InterPro; IPR000987; EDG1_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR004061; S1P_rcpt.
DR   PANTHER; PTHR22750:SF16; PTHR22750:SF16; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01523; S1PRECEPTOR.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Angiogenesis; Cell membrane; Chemotaxis;
KW   Disulfide bond; Endosome; G-protein coupled receptor; Glycoprotein;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..382
FT                   /note="Sphingosine 1-phosphate receptor 1"
FT                   /id="PRO_0000069412"
FT   TOPO_DOM        1..46
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        47..68
FT                   /note="Helical; Name=1"
FT   TOPO_DOM        69..82
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        83..104
FT                   /note="Helical; Name=2"
FT   TOPO_DOM        105..116
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        117..138
FT                   /note="Helical; Name=3"
FT   TOPO_DOM        139..160
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        161..182
FT                   /note="Helical; Name=4"
FT   TOPO_DOM        183..196
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        197..224
FT                   /note="Helical; Name=5"
FT   TOPO_DOM        225..257
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        258..278
FT                   /note="Helical; Name=6"
FT   TOPO_DOM        279..289
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   TRANSMEM        290..310
FT                   /note="Helical; Name=7"
FT   TOPO_DOM        311..382
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15750791"
FT   REGION          120..121
FT                   /note="Sphingosine 1-phosphate binding"
FT   REGION          265..269
FT                   /note="Sphingosine 1-phosphate binding"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O08530"
FT   MOD_RES         236
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:11583630"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O08530"
FT   MOD_RES         353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   LIPID           328
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15750791,
FT                   ECO:0000269|PubMed:22344443"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        184..191
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:22344443"
FT   DISULFID        282..287
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521,
FT                   ECO:0000269|PubMed:22344443"
FT   VARIANT         15
FT                   /note="S -> L (in dbSNP:rs4987250)"
FT                   /id="VAR_046158"
FT   VARIANT         115
FT                   /note="A -> T (in dbSNP:rs11542632)"
FT                   /id="VAR_046159"
FT   VARIANT         332
FT                   /note="P -> R (in dbSNP:rs7549921)"
FT                   /id="VAR_046160"
FT   MUTAGEN         120
FT                   /note="R->A: Drastically reduced affinity for sphingosine
FT                   1-phosphate."
FT                   /evidence="ECO:0000269|PubMed:10982820"
FT   MUTAGEN         121
FT                   /note="E->A: Drastically reduced affinity for sphingosine
FT                   1-phosphate."
FT                   /evidence="ECO:0000269|PubMed:10982820"
FT   MUTAGEN         121
FT                   /note="E->Q: Slight activation of the receptor at maximal
FT                   ligand concentration."
FT                   /evidence="ECO:0000269|PubMed:10982820"
FT   MUTAGEN         210
FT                   /note="F->L: Impairs sphingosine 1-phosphate binding and
FT                   signaling."
FT                   /evidence="ECO:0000269|PubMed:22344443"
FT   MUTAGEN         236
FT                   /note="T->A: Acts as a dominant negative GPCR and inhibits
FT                   S1P-induced Rac activation, chemotaxis, and angiogenesis."
FT                   /evidence="ECO:0000269|PubMed:11583630"
FT   MUTAGEN         265
FT                   /note="F->L: Impairs sphingosine 1-phosphate binding and
FT                   signaling."
FT                   /evidence="ECO:0000269|PubMed:22344443"
FT   MUTAGEN         269
FT                   /note="W->F,L: Impairs sphingosine 1-phosphate binding and
FT                   signaling."
FT                   /evidence="ECO:0000269|PubMed:22344443"
FT   MUTAGEN         292
FT                   /note="R->A,V: Drastically reduced affinity for sphingosine
FT                   1-phosphate."
FT                   /evidence="ECO:0000269|PubMed:10982820"
FT   CONFLICT        250..252
FT                   /note="KSL -> NV (in Ref. 1; AAA52336 and 2; AAC51905)"
FT                   /evidence="ECO:0000305"
FT   HELIX           23..31
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           36..39
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           42..72
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           74..76
FT                   /evidence="ECO:0000244|PDB:3V2W"
FT   HELIX           79..104
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           106..109
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           114..146
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           158..176
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   TURN            177..181
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           188..190
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   STRAND          193..195
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           200..231
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   TURN            247..249
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           251..280
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   TURN            284..286
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   TURN            289..291
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           294..302
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           303..305
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           307..314
FT                   /evidence="ECO:0000244|PDB:3V2Y"
FT   HELIX           316..323
FT                   /evidence="ECO:0000244|PDB:3V2Y"
SQ   SEQUENCE   382 AA;  42811 MW;  0CCE8685A5E1BAD2 CRC64;
     MGPTSVPLVK AHRSSVSDYV NYDIIVRHYN YTGKLNISAD KENSIKLTSV VFILICCFII
     LENIFVLLTI WKTKKFHRPM YYFIGNLALS DLLAGVAYTA NLLLSGATTY KLTPAQWFLR
     EGSMFVALSA SVFSLLAIAI ERYITMLKMK LHNGSNNFRL FLLISACWVI SLILGGLPIM
     GWNCISALSS CSTVLPLYHK HYILFCTTVF TLLLLSIVIL YCRIYSLVRT RSRRLTFRKN
     ISKASRSSEK SLALLKTVII VLSVFIACWA PLFILLLLDV GCKVKTCDIL FRAEYFLVLA
     VLNSGTNPII YTLTNKEMRR AFIRIMSCCK CPSGDSAGKF KRPIIAGMEF SRSKSDNSSH
     PQKDEGDNPE TIMSSGNVNS SS
//
ID   PE2R4_HUMAN             Reviewed;         488 AA.
AC   P35408; Q3MJ87;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   12-AUG-2020, entry version 186.
DE   RecName: Full=Prostaglandin E2 receptor EP4 subtype;
DE            Short=PGE receptor EP4 subtype;
DE            Short=PGE2 receptor EP4 subtype;
DE   AltName: Full=Prostanoid EP4 receptor;
GN   Name=PTGER4; Synonyms=PTGER2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=8163486;
RA   Bastien L., Sawyer N., Grygorczyk R., Metters K.M., Adam M.;
RT   "Cloning, functional expression, and characterization of the human
RT   prostaglandin E2 receptor EP2 subtype.";
RL   J. Biol. Chem. 269:11873-11877(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=8250933; DOI=10.1006/bbrc.1993.2470;
RA   An S., Yang J., Xia M., Goetzl E.J.;
RT   "Cloning and expression of the EP2 subtype of human receptors for
RT   prostaglandin E2.";
RL   Biochem. Biophys. Res. Commun. 197:263-270(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8661119; DOI=10.1006/geno.1996.0337;
RA   Foord S.M., Marks B., Stolz M., Bufflier E., Fraser N.J., Lee M.G.;
RT   "The structure of the prostaglandin EP4 receptor gene and related
RT   pseudogenes.";
RL   Genomics 35:182-188(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=8862514; DOI=10.1007/bf00207510;
RA   Mori K., Tanaka I., Kotani M., Miyaoka F., Sando T., Muro S., Sasaki Y.,
RA   Nakagawa O., Ogawa Y., Usui T., Ozaki S., Ichikawa A., Narumiya S.,
RA   Nakao K.;
RT   "Gene expression of the human prostaglandin E receptor EP4 subtype:
RT   differential regulation in monocytoid and lymphoid lineage cells by phorbol
RT   ester.";
RL   J. Mol. Med. 74:333-336(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION.
RX   PubMed=11597569; DOI=10.1016/s0006-2952(01)00742-0;
RA   Slipetz D., Buchanan S., Mackereth C., Brewer N., Pellow V., Hao C.,
RA   Adam M., Abramovitz M., Metters K.M.;
RT   "Sequestration and phosphorylation of the prostaglandin E2 EP4 receptor:
RT   dependence on the C-terminal tail.";
RL   Biochem. Pharmacol. 62:997-1012(2001).
RN   [9]
RP   PHOSPHORYLATION AT SER-374; SER-377; SER-379 AND SER-382.
RX   PubMed=14709160; DOI=10.1042/bj20031820;
RA   Neuschafer-Rube F., Hermosilla R., Rehwald M., Ronnstrand L., Schulein R.,
RA   Wernstedt C., Puschel G.P.;
RT   "Identification of a Ser/Thr cluster in the C-terminal domain of the human
RT   prostaglandin receptor EP4 that is essential for agonist-induced beta-
RT   arrestin1 recruitment but differs from the apparent principal
RT   phosphorylation site.";
RL   Biochem. J. 379:573-585(2004).
RN   [10]
RP   INTERACTION WITH FEM1A.
RX   PubMed=16424369; DOI=10.1161/01.res.0000204451.88147.96;
RA   Takayama K., Sukhova G.K., Chin M.T., Libby P.;
RT   "A novel prostaglandin E receptor 4-associated protein participates in
RT   antiinflammatory signaling.";
RL   Circ. Res. 98:499-504(2006).
CC   -!- FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this
CC       receptor is mediated by G(s) proteins that stimulate adenylate cyclase.
CC       Has a relaxing effect on smooth muscle. May play an important role in
CC       regulating renal hemodynamics, intestinal epithelial transport, adrenal
CC       aldosterone secretion, and uterine function.
CC   -!- SUBUNIT: Interacts with FEM1A. {ECO:0000269|PubMed:16424369}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: High in intestine and in peripheral blood
CC       mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and
CC       brain. Not found in liver, heart, retina oe skeletal muscle.
CC   -!- PTM: Phosphorylation mediates agonist-mediated desensitization by
CC       promoting cytoplasmic retention. {ECO:0000269|PubMed:11597569,
CC       ECO:0000269|PubMed:14709160}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- CAUTION: Was originally designated as the EP2 subtype. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ptger4/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L28175; AAA36434.1; -; mRNA.
DR   EMBL; L25124; AAA36438.1; -; mRNA.
DR   EMBL; X97873; CAA66463.1; -; Genomic_DNA.
DR   EMBL; X97874; CAA66463.1; JOINED; Genomic_DNA.
DR   EMBL; D28472; BAA05834.1; -; mRNA.
DR   EMBL; AY429109; AAR07904.1; -; mRNA.
DR   EMBL; DQ400918; ABD48960.1; -; Genomic_DNA.
DR   EMBL; BC101534; AAI01535.1; -; mRNA.
DR   EMBL; BC113523; AAI13524.1; -; mRNA.
DR   CCDS; CCDS3930.1; -.
DR   PIR; A53572; A53572.
DR   RefSeq; NP_000949.1; NM_000958.2.
DR   PDB; 5YHL; X-ray; 4.20 A; A=4-366.
DR   PDB; 5YWY; X-ray; 3.20 A; A=4-366.
DR   PDBsum; 5YHL; -.
DR   PDBsum; 5YWY; -.
DR   SMR; P35408; -.
DR   BioGRID; 111706; 6.
DR   DIP; DIP-61099N; -.
DR   IntAct; P35408; 43.
DR   MINT; P35408; -.
DR   STRING; 9606.ENSP00000302846; -.
DR   BindingDB; P35408; -.
DR   ChEMBL; CHEMBL1836; -.
DR   DrugBank; DB11113; Castor oil.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB12836; Grapiprant.
DR   DrugBank; DB09211; Limaprost.
DR   DrugBank; DB00929; Misoprostol.
DR   DrugCentral; P35408; -.
DR   GuidetoPHARMACOLOGY; 343; -.
DR   GlyGen; P35408; 1 site.
DR   iPTMnet; P35408; -.
DR   PhosphoSitePlus; P35408; -.
DR   BioMuta; PTGER4; -.
DR   DMDM; 548476; -.
DR   jPOST; P35408; -.
DR   MassIVE; P35408; -.
DR   MaxQB; P35408; -.
DR   PaxDb; P35408; -.
DR   PeptideAtlas; P35408; -.
DR   PRIDE; P35408; -.
DR   ProteomicsDB; 55059; -.
DR   Antibodypedia; 2762; 354 antibodies.
DR   DNASU; 5734; -.
DR   Ensembl; ENST00000302472; ENSP00000302846; ENSG00000171522.
DR   GeneID; 5734; -.
DR   KEGG; hsa:5734; -.
DR   UCSC; uc003jlz.5; human.
DR   CTD; 5734; -.
DR   DisGeNET; 5734; -.
DR   EuPathDB; HostDB:ENSG00000171522.5; -.
DR   GeneCards; PTGER4; -.
DR   HGNC; HGNC:9596; PTGER4.
DR   HPA; ENSG00000171522; Tissue enhanced (pancreas).
DR   MIM; 601586; gene.
DR   neXtProt; NX_P35408; -.
DR   OpenTargets; ENSG00000171522; -.
DR   PharmGKB; PA289; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01000000214437; -.
DR   HOGENOM; CLU_045991_0_2_1; -.
DR   InParanoid; P35408; -.
DR   KO; K04261; -.
DR   OMA; LLYMPDL; -.
DR   OrthoDB; 972015at2759; -.
DR   PhylomeDB; P35408; -.
DR   TreeFam; TF324982; -.
DR   PathwayCommons; P35408; -.
DR   Reactome; R-HSA-391908; Prostanoid ligand receptors.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SABIO-RK; P35408; -.
DR   SIGNOR; P35408; -.
DR   BioGRID-ORCS; 5734; 2 hits in 876 CRISPR screens.
DR   ChiTaRS; PTGER4; human.
DR   GeneWiki; EP4_receptor; -.
DR   GenomeRNAi; 5734; -.
DR   Pharos; P35408; Tclin.
DR   PRO; PR:P35408; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P35408; protein.
DR   Bgee; ENSG00000171522; Expressed in metanephric glomerulus and 222 other tissues.
DR   Genevisible; P35408; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004957; F:prostaglandin E receptor activity; IDA:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060348; P:bone development; ISS:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IBA:GO_Central.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IEP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0007254; P:JNK cascade; ISS:UniProtKB.
DR   GO; GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB.
DR   GO; GO:2000420; P:negative regulation of eosinophil extravasation; IDA:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB.
DR   GO; GO:0033624; P:negative regulation of integrin activation; IDA:UniProtKB.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0042093; P:T-helper cell differentiation; ISS:UniProtKB.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001758; Prost_EP4_rcpt.
DR   InterPro; IPR008365; Prostanoid_rcpt.
DR   InterPro; IPR001244; Prostglndn_DP_rcpt.
DR   PANTHER; PTHR11866; PTHR11866; 1.
DR   PANTHER; PTHR11866:SF6; PTHR11866:SF6; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00428; PROSTAGLNDNR.
DR   PRINTS; PR01788; PROSTANOIDR.
DR   PRINTS; PR00586; PRSTNOIDEP4R.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..488
FT                   /note="Prostaglandin E2 receptor EP4 subtype"
FT                   /id="PRO_0000070064"
FT   TOPO_DOM        1..19
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        20..43
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        44..55
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        56..79
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        80..96
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        97..115
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        116..135
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..160
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        161..184
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..211
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        212..267
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        268..295
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        296..312
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        313..332
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        333..488
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        230..234
FT                   /note="Poly-Ala"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:14709160"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:14709160"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:14709160"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:14709160"
FT   CARBOHYD        7
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        92..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        464..466
FT                   /note="GPA -> WAC (in Ref. 2; AAA36438)"
FT                   /evidence="ECO:0000305"
FT   HELIX           19..41
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   STRAND          44..46
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           52..82
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           89..122
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           125..128
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           134..152
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   TURN            153..156
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   STRAND          161..163
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   TURN            165..167
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   STRAND          170..172
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           179..213
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           267..283
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           286..297
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   TURN            306..308
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           310..319
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           321..331
FT                   /evidence="ECO:0000244|PDB:5YWY"
FT   HELIX           334..343
FT                   /evidence="ECO:0000244|PDB:5YWY"
SQ   SEQUENCE   488 AA;  53119 MW;  D028478CD72C85EE CRC64;
     MSTPGVNSSA SLSPDRLNSP VTIPAVMFIF GVVGNLVAIV VLCKSRKEQK ETTFYTLVCG
     LAVTDLLGTL LVSPVTIATY MKGQWPGGQP LCEYSTFILL FFSLSGLSII CAMSVERYLA
     INHAYFYSHY VDKRLAGLTL FAVYASNVLF CALPNMGLGS SRLQYPDTWC FIDWTTNVTA
     HAAYSYMYAG FSSFLILATV LCNVLVCGAL LRMHRQFMRR TSLGTEQHHA AAAASVASRG
     HPAASPALPR LSDFRRRRSF RRIAGAEIQM VILLIATSLV VLICSIPLVV RVFVNQLYQP
     SLEREVSKNP DLQAIRIASV NPILDPWIYI LLRKTVLSKA IEKIKCLFCR IGGSRRERSG
     QHCSDSQRTS SAMSGHSRSF ISRELKEISS TSQTLLPDLS LPDLSENGLG GRNLLPGVPG
     MGLAQEDTTS LRTLRISETS DSSQGQDSES VLLVDEAGGS GRAGPAPKGS SLQVTFPSET
     LNLSEKCI
//
ID   AGRB3_HUMAN             Reviewed;        1522 AA.
AC   O60242; B7Z1K0; O60297; Q2NKN6; Q5VY37; Q9BX54;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   07-OCT-2020, entry version 181.
DE   RecName: Full=Adhesion G protein-coupled receptor B3 {ECO:0000303|PubMed:25713288};
DE   AltName: Full=Brain-specific angiogenesis inhibitor 3;
DE   Flags: Precursor;
GN   Name=ADGRB3 {ECO:0000312|HGNC:HGNC:945}; Synonyms=BAI3, KIAA0550;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-503, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=9533023; DOI=10.1159/000134693;
RA   Shiratsuchi T., Nishimori H., Ichise H., Nakamura Y., Tokino T.;
RT   "Cloning and characterization of BAI2 and BAI3, novel genes homologous to
RT   brain-specific angiogenesis inhibitor 1 (BAI1).";
RL   Cytogenet. Cell Genet. 79:103-108(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-503.
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   SEQUENCE REVISION TO 643-665 AND C-TERMINUS.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-503.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-619, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH C1QL1; C1QL2; C1QL3 AND C1QL4.
RX   PubMed=21262840; DOI=10.1073/pnas.1019577108;
RA   Bolliger M.F., Martinelli D.C., Sudhof T.C.;
RT   "The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity
RT   receptor for C1q-like proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:2534-2539(2011).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ELMO1; ELMO2 AND ELMO3.
RX   PubMed=24567399; DOI=10.1073/pnas.1313886111;
RA   Hamoud N., Tran V., Croteau L.P., Kania A., Cote J.F.;
RT   "G-protein coupled receptor BAI3 promotes myoblast fusion in vertebrates.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:3745-3750(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 498-868, PROTEOLYTIC PROCESSING,
RP   GLYCOSYLATION AT ASN-540 AND ASN-625, DISULFIDE BONDS, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22333914; DOI=10.1038/emboj.2012.26;
RA   Arac D., Boucard A.A., Bolliger M.F., Nguyen J., Soltis S.M., Sudhof T.C.,
RA   Brunger A.T.;
RT   "A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates
RT   autoproteolysis.";
RL   EMBO J. 31:1364-1378(2012).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=25713288; DOI=10.1124/pr.114.009647;
RA   Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R.,
RA   Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A., Liebscher I.,
RA   Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C., Piao X., Promel S.,
RA   Schoneberg T., Schwartz T.W., Singer K., Stacey M., Ushkaryov Y.A.,
RA   Vallon M., Wolfrum U., Wright M.W., Xu L., Langenhan T., Schioth H.B.;
RT   "International union of basic and clinical pharmacology. XCIV. Adhesion G
RT   protein-coupled receptors.";
RL   Pharmacol. Rev. 67:338-367(2015).
CC   -!- FUNCTION: Receptor that plays a role in the regulation of
CC       synaptogenesis and dendritic spine formation at least partly via
CC       interaction with ELMO1 and RAC1 activity (By similarity). Promotes
CC       myoblast fusion through ELMO/DOCK1 (PubMed:24567399).
CC       {ECO:0000250|UniProtKB:Q80ZF8, ECO:0000269|PubMed:24567399}.
CC   -!- SUBUNIT: Forms a heterodimer, consisting of a large extracellular
CC       region non-covalently linked to a seven-transmembrane moiety. Interacts
CC       (via TSP N-terminal domains) with C1QL1, C1QL2, C1QL3 and C1QL4
CC       (PubMed:21262840). Interacts with ELMO1, ELMO2 AND ELMO3
CC       (PubMed:24567399). {ECO:0000269|PubMed:21262840,
CC       ECO:0000269|PubMed:24567399}.
CC   -!- INTERACTION:
CC       O60242; Q8N954: GPATCH11; NbExp=3; IntAct=EBI-2682765, EBI-2555378;
CC       O60242; O60883: GPR37L1; NbExp=3; IntAct=EBI-2682765, EBI-2927498;
CC       O60242; P15941-11: MUC1; NbExp=3; IntAct=EBI-2682765, EBI-17263240;
CC       O60242; P30825: SLC7A1; NbExp=3; IntAct=EBI-2682765, EBI-4289564;
CC       O60242; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-2682765, EBI-12947623;
CC       O60242; Q9ESN4: C1ql3; Xeno; NbExp=4; IntAct=EBI-2682765, EBI-15907894;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21262840,
CC       ECO:0000269|PubMed:22333914}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60242-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60242-2; Sequence=VSP_056939;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in brain. Also detected in
CC       heart. Reduced expression in some glioblastoma cell lines.
CC       {ECO:0000269|PubMed:9533023}.
CC   -!- PTM: The endogenous protein is proteolytically cleaved into 2 subunits,
CC       an extracellular subunit and a seven-transmembrane subunit.
CC       {ECO:0000269|PubMed:22333914}.
CC   -!- MISCELLANEOUS: Autoproteolysis appears to be cell specific, does not
CC       readily undergo proteolytic cleavage in HEK293T cells.
CC       {ECO:0000269|PubMed:25713288}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       Adhesion G-protein coupled receptor (ADGR) subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25476.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB005299; BAA25363.1; -; mRNA.
DR   EMBL; AB011122; BAA25476.2; ALT_INIT; mRNA.
DR   EMBL; AK293560; BAH11536.1; -; mRNA.
DR   EMBL; AL035469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL078598; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589875; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158051; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359714; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL391807; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48837.1; -; Genomic_DNA.
DR   EMBL; BC111720; AAI11721.1; -; mRNA.
DR   CCDS; CCDS4968.1; -. [O60242-1]
DR   PIR; T00028; T00028.
DR   PIR; T00326; T00326.
DR   RefSeq; NP_001695.1; NM_001704.2. [O60242-1]
DR   RefSeq; XP_005248809.1; XM_005248752.2.
DR   PDB; 4DLO; X-ray; 2.30 A; A/B=498-868.
DR   PDBsum; 4DLO; -.
DR   SMR; O60242; -.
DR   BioGRID; 107053; 7.
DR   DIP; DIP-56121N; -.
DR   IntAct; O60242; 9.
DR   STRING; 9606.ENSP00000359630; -.
DR   MEROPS; P02.027; -.
DR   TCDB; 9.A.14.6.7; the g-protein-coupled receptor (gpcr) family.
DR   GlyConnect; 2016; 1 N-Linked glycan (1 site).
DR   GlyGen; O60242; 14 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; O60242; -.
DR   PhosphoSitePlus; O60242; -.
DR   BioMuta; ADGRB3; -.
DR   MassIVE; O60242; -.
DR   PaxDb; O60242; -.
DR   PeptideAtlas; O60242; -.
DR   PRIDE; O60242; -.
DR   ProteomicsDB; 49275; -. [O60242-1]
DR   ProteomicsDB; 6341; -.
DR   Antibodypedia; 2938; 231 antibodies.
DR   Ensembl; ENST00000370598; ENSP00000359630; ENSG00000135298. [O60242-1]
DR   Ensembl; ENST00000546190; ENSP00000441821; ENSG00000135298. [O60242-1]
DR   GeneID; 577; -.
DR   KEGG; hsa:577; -.
DR   UCSC; uc003pev.5; human. [O60242-1]
DR   CTD; 577; -.
DR   DisGeNET; 577; -.
DR   EuPathDB; HostDB:ENSG00000135298.13; -.
DR   GeneCards; ADGRB3; -.
DR   HGNC; HGNC:945; ADGRB3.
DR   HPA; ENSG00000135298; Group enriched (brain, pituitary gland).
DR   MIM; 602684; gene.
DR   neXtProt; NX_O60242; -.
DR   OpenTargets; ENSG00000135298; -.
DR   PharmGKB; PA25249; -.
DR   eggNOG; ENOG502QRKJ; Eukaryota.
DR   GeneTree; ENSGT00940000155081; -.
DR   HOGENOM; CLU_003751_1_0_1; -.
DR   InParanoid; O60242; -.
DR   KO; K04598; -.
DR   OMA; LWDDSRT; -.
DR   OrthoDB; 27621at2759; -.
DR   PhylomeDB; O60242; -.
DR   TreeFam; TF331634; -.
DR   PathwayCommons; O60242; -.
DR   BioGRID-ORCS; 577; 6 hits in 869 CRISPR screens.
DR   ChiTaRS; ADGRB3; human.
DR   GeneWiki; Brain-specific_angiogenesis_inhibitor_3; -.
DR   GenomeRNAi; 577; -.
DR   Pharos; O60242; Tbio.
DR   PRO; PR:O60242; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O60242; protein.
DR   Bgee; ENSG00000135298; Expressed in middle temporal gyrus and 156 other tissues.
DR   ExpressionAtlas; O60242; baseline and differential.
DR   Genevisible; O60242; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:GDB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IPI:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IBA:GO_Central.
DR   GO; GO:0043083; C:synaptic cleft; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:GDB.
DR   GO; GO:0099558; P:maintenance of synapse structure; IEA:Ensembl.
DR   GO; GO:0061743; P:motor learning; IEA:Ensembl.
DR   GO; GO:0007520; P:myoblast fusion; IDA:UniProtKB.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:InterPro.
DR   GO; GO:0016322; P:neuron remodeling; IBA:GO_Central.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; ISS:UniProtKB.
DR   Gene3D; 2.20.100.10; -; 4.
DR   Gene3D; 4.10.1240.10; -; 1.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR032471; GAIN_dom_N.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR008077; GPCR_2_brain_angio_inhib.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF16489; GAIN; 1.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF02793; HRM; 1.
DR   Pfam; PF00090; TSP_1; 4.
DR   PRINTS; PR01694; BAIPRECURSOR.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00008; HormR; 1.
DR   SMART; SM00209; TSP1; 4.
DR   SUPFAM; SSF82895; SSF82895; 4.
DR   PROSITE; PS01180; CUB; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GPS; 1.
DR   PROSITE; PS50092; TSP1; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..1522
FT                   /note="Adhesion G protein-coupled receptor B3"
FT                   /id="PRO_0000012865"
FT   TOPO_DOM        25..880
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        881..901
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        902..910
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        911..931
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        932..939
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        940..960
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        961..981
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        982..1002
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1003..1023
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1024..1044
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1045..1098
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1099..1119
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1120..1125
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1126..1146
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1147..1522
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          30..159
FT                   /note="CUB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          291..343
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          345..398
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          400..453
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          455..508
FT                   /note="TSP type-1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          816..868
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   COMPBIAS        942..945
FT                   /note="Poly-Thr"
FT   COMPBIAS        1173..1176
FT                   /note="Poly-Ser"
FT   MOD_RES         619
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80ZF8"
FT   MOD_RES         1411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80ZF8"
FT   CARBOHYD        51
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        418
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        540
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   CARBOHYD        625
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   CARBOHYD        779
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        812
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        828
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        937
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        30..55
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DISULFID        303..336
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        307..342
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        318..326
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        357..392
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        361..397
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        372..382
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        412..447
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        416..452
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        427..437
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        467..502
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        471..507
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        482..492
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        514..549
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   DISULFID        537..567
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   DISULFID        819..851
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   DISULFID        839..853
FT                   /evidence="ECO:0000269|PubMed:22333914"
FT   VAR_SEQ         1..1036
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056939"
FT   VARIANT         503
FT                   /note="N -> S (in dbSNP:rs1932618)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9533023, ECO:0000269|PubMed:9628581"
FT                   /id="VAR_046525"
FT   TURN            502..504
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   TURN            519..521
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          532..535
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          541..551
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          557..559
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          563..569
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           570..583
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           589..608
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           613..632
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           639..652
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           655..657
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           658..664
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   TURN            665..667
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           670..687
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          694..698
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          700..710
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          718..721
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           730..734
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          738..741
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           743..746
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          759..769
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   HELIX           770..772
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          781..783
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          787..794
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          803..808
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          815..823
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          833..835
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          839..845
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          848..855
FT                   /evidence="ECO:0000244|PDB:4DLO"
FT   STRAND          857..864
FT                   /evidence="ECO:0000244|PDB:4DLO"
SQ   SEQUENCE   1522 AA;  171518 MW;  D22D0A5CF59E811F CRC64;
     MKAVRNLLIY IFSTYLLVMF GFNAAQDFWC STLVKGVIYG SYSVSEMFPK NFTNCTWTLE
     NPDPTKYSIY LKFSKKDLSC SNFSLLAYQF DHFSHEKIKD LLRKNHSIMQ LCNSKNAFVF
     LQYDKNFIQI RRVFPTNFPG LQKKGEEDQK SFFEFLVLNK VSPSQFGCHV LCTWLESCLK
     SENGRTESCG IMYTKCTCPQ HLGEWGIDDQ SLILLNNVVL PLNEQTEGCL TQELQTTQVC
     NLTREAKRPP KEEFGMMGDH TIKSQRPRSV HEKRVPQEQA DAAKFMAQTG ESGVEEWSQW
     STCSVTCGQG SQVRTRTCVS PYGTHCSGPL RESRVCNNTA LCPVHGVWEE WSPWSLCSFT
     CGRGQRTRTR SCTPPQYGGR PCEGPETHHK PCNIALCPVD GQWQEWSSWS QCSVTCSNGT
     QQRSRQCTAA AHGGSECRGP WAESRECYNP ECTANGQWNQ WGHWSGCSKS CDGGWERRIR
     TCQGAVITGQ QCEGTGEEVR RCNEQRCPAP YEICPEDYLM SMVWKRTPAG DLAFNQCPLN
     ATGTTSRRCS LSLHGVAFWE QPSFARCISN EYRHLQHSIK EHLAKGQRML AGDGMSQVTK
     TLLDLTQRKN FYAGDLLMSV EILRNVTDTF KRASYIPASD GVQNFFQIVS NLLDEENKEK
     WEDAQQIYPG SIELMQVIED FIHIVGMGMM DFQNSYLMTG NVVASIQKLP AASVLTDINF
     PMKGRKGMVD WARNSEDRVV IPKSIFTPVS SKELDESSVF VLGAVLYKNL DLILPTLRNY
     TVINSKIIVV TIRPEPKTTD SFLEIELAHL ANGTLNPYCV LWDDSKTNES LGTWSTQGCK
     TVLTDASHTK CLCDRLSTFA ILAQQPREII MESSGTPSVT LIVGSGLSCL ALITLAVVYA
     ALWRYIRSER SIILINFCLS IISSNILILV GQTQTHNKSI CTTTTAFLHF FFLASFCWVL
     TEAWQSYMAV TGKIRTRLIR KRFLCLGWGL PALVVATSVG FTRTKGYGTD HYCWLSLEGG
     LLYAFVGPAA AVVLVNMVIG ILVFNKLVSR DGILDKKLKH RAGQMSEPHS GLTLKCAKCG
     VVSTTALSAT TASNAMASLW SSCVVLPLLA LTWMSAVLAM TDKRSILFQI LFAVFDSLQG
     FVIVMVHCIL RREVQDAFRC RLRNCQDPIN ADSSSSFPNG HAQIMTDFEK DVDIACRSVL
     HKDIGPCRAA TITGTLSRIS LNDDEEEKGT NPEGLSYSTL PGNVISKVII QQPTGLHMPM
     SMNELSNPCL KKENSELRRT VYLCTDDNLR GADMDIVHPQ ERMMESDYIV MPRSSVNNQP
     SMKEESKMNI GMETLPHERL LHYKVNPEFN MNPPVMDQFN MNLEQHLAPQ EHMQNLPFEP
     RTAVKNFMAS ELDDNAGLSR SETGSTISMS SLERRKSRYS DLDFEKVMHT RKRHMELFQE
     LNQKFQTLDR FRDIPNTSSM ENPAPNKNPW DTFKNPSEYP HYTTINVLDT EAKDALELRP
     AEWEKCLNLP LDVQEGDFQT EV
//
ID   CRFR2_HUMAN             Reviewed;         411 AA.
AC   Q13324; B2R967; B3SXS6; B3SXS7; B3SXS8; B3SXT0; F8WA81; O43461; Q4QRJ4;
AC   Q99431;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   07-OCT-2020, entry version 170.
DE   RecName: Full=Corticotropin-releasing factor receptor 2;
DE            Short=CRF-R-2;
DE            Short=CRF-R2;
DE            Short=CRFR-2;
DE   AltName: Full=Corticotropin-releasing hormone receptor 2;
DE            Short=CRH-R-2;
DE            Short=CRH-R2;
GN   Name=CRHR2; Synonyms=CRF2R, CRH2R;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF2-ALPHA).
RX   PubMed=8536644; DOI=10.1210/endo.137.1.8536644;
RA   Liaw C.W., Lovenberg T.W., Barry G., Oltersdorf T., Grigoriadis D.E.,
RA   de Souza E.B.;
RT   "Cloning and characterization of the human corticotropin-releasing factor-2
RT   receptor complementary deoxyribonucleic acid.";
RL   Endocrinology 137:72-77(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF2-BETA).
RC   TISSUE=Amygdala;
RA   Kostich W.A., Chen A., Sperle K., Horlick R.A., Patterson J., Hyde T.M.,
RA   Largent B.L.;
RT   "Molecular cloning of the human CRH2B receptor isoform: divergence from the
RT   rodent isoform in sequence and expression pattern.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF2-GAMMA).
RC   TISSUE=Amygdala;
RX   PubMed=9717834; DOI=10.1210/mend.12.8.0145;
RA   Kostich W.A., Chen A., Sperle K., Largent B.L.;
RT   "Molecular identification and analysis of a novel human corticotropin-
RT   releasing factor (CRF) receptor: the CRF2gamma receptor.";
RL   Mol. Endocrinol. 12:1077-1085(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM CRF2-ALPHA).
RA   Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S.,
RA   Tsutsumi S., Aburatani H., Asai K., Akiyama Y.;
RT   "Genome-wide discovery and analysis of human seven transmembrane helix
RT   receptor genes.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF2-ALPHA).
RC   TISSUE=Brain;
RA   King M.M., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS D; E; F AND DESQ), AND ALTERNATIVE
RP   SPLICING.
RA   Wu S.V., Yuan P.-Q., Lai J., Tache Y.;
RT   "Identification and characterization of novel CRF receptor type 2 isoforms
RT   in human.";
RL   Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF2-ALPHA).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF2-ALPHA).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-88 (ISOFORM CRF2-BETA).
RC   TISSUE=Skeletal muscle;
RX   PubMed=9199241; DOI=10.1016/s0167-4781(97)00047-x;
RA   Valdenaire O., Giller T., Breu V., Gottowik J., Kilpatrick G.;
RT   "A new functional isoform of the human CRF2 receptor for corticotropin-
RT   releasing factor.";
RL   Biochim. Biophys. Acta 1352:129-132(1997).
RN   [11]
RP   SUBUNIT, SUBCELLULAR LOCATION, AND NON-CLEAVABLE SIGNAL SEQUENCE.
RX   PubMed=22689579; DOI=10.1074/jbc.m112.360594;
RA   Teichmann A., Rutz C., Kreuchwig A., Krause G., Wiesner B., Schulein R.;
RT   "The Pseudo signal peptide of the corticotropin-releasing factor receptor
RT   type 2A prevents receptor oligomerization.";
RL   J. Biol. Chem. 287:27265-27274(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 3-104 IN COMPLEXES WITH UCN; UCN2
RP   AND UCN3, INTERACTION WITH CRF; UCN; UCN2 AND UCN3, AND DISULFIDE BONDS.
RX   PubMed=20966082; DOI=10.1074/jbc.m110.186072;
RA   Pal K., Swaminathan K., Xu H.E., Pioszak A.A.;
RT   "Structural basis for hormone recognition by the Human CRFR2{alpha} G
RT   protein-coupled receptor.";
RL   J. Biol. Chem. 285:40351-40361(2010).
CC   -!- FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing
CC       factor), UCN (urocortin), UCN2 and UCN3. Has high affinity for UCN.
CC       Ligand binding causes a conformation change that triggers signaling via
CC       guanine nucleotide-binding proteins (G proteins) and down-stream
CC       effectors, such as adenylate cyclase. Promotes the activation of
CC       adenylate cyclase, leading to increased intracellular cAMP levels.
CC   -!- SUBUNIT: Monomer. Interacts (via N-terminal extracellular domain) with
CC       CRF, UCN, UCN2 and UCN3. Has highest affinity for UCN, and considerably
CC       lower affinity for CRF, UNC2 and UCN3. {ECO:0000269|PubMed:20966082,
CC       ECO:0000269|PubMed:22689579}.
CC   -!- INTERACTION:
CC       Q13324-2; Q13021: MALL; NbExp=3; IntAct=EBI-23865243, EBI-750078;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22689579};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:22689579}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=CRF2-alpha;
CC         IsoId=Q13324-1; Sequence=Displayed;
CC       Name=CRF2-beta;
CC         IsoId=Q13324-2; Sequence=VSP_001999;
CC       Name=CRF2-gamma;
CC         IsoId=Q13324-3; Sequence=VSP_002000;
CC       Name=D;
CC         IsoId=Q13324-4; Sequence=VSP_053565;
CC       Name=E;
CC         IsoId=Q13324-5; Sequence=VSP_053566;
CC       Name=F;
CC         IsoId=Q13324-6; Sequence=VSP_053567;
CC       Name=desQ;
CC         IsoId=Q13324-7; Sequence=VSP_053564;
CC   -!- DOMAIN: The transmembrane domain is composed of seven transmembrane
CC       helices that are arranged in V-shape. Transmembrane helix 7 assumes a
CC       sharply kinked structure (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The uncleaved pseudo signal peptide prevents receptor's
CC       oligomerization and coupling to G(i) subunits. It is also responsible
CC       for the rather low receptor localization at the plasma membrane
CC       (PubMed:22689579). {ECO:0000269|PubMed:22689579}.
CC   -!- PTM: A N-glycosylation site within the signal peptide impedes its
CC       proper cleavage and function. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U34587; AAA91320.1; -; mRNA.
DR   EMBL; AF011406; AAB94503.1; -; mRNA.
DR   EMBL; AF019381; AAB94562.1; -; mRNA.
DR   EMBL; AB065699; BAC05922.1; -; Genomic_DNA.
DR   EMBL; AY449734; AAR18078.1; -; mRNA.
DR   EMBL; EU012439; ABV59313.1; -; mRNA.
DR   EMBL; EU012440; ABV59314.1; -; mRNA.
DR   EMBL; EU012441; ABV59315.1; -; mRNA.
DR   EMBL; EU012443; ABV59317.1; -; mRNA.
DR   EMBL; AK313661; BAG36414.1; -; mRNA.
DR   EMBL; AC004976; AAC71653.1; -; Genomic_DNA.
DR   EMBL; AC004976; AAC71654.1; -; Genomic_DNA.
DR   EMBL; BC096830; AAH96830.1; -; mRNA.
DR   EMBL; Y10151; CAA71235.1; -; mRNA.
DR   CCDS; CCDS5429.1; -. [Q13324-1]
DR   CCDS; CCDS56477.1; -. [Q13324-3]
DR   CCDS; CCDS56478.1; -. [Q13324-2]
DR   CCDS; CCDS75576.1; -. [Q13324-4]
DR   RefSeq; NP_001189404.1; NM_001202475.1. [Q13324-2]
DR   RefSeq; NP_001189410.1; NM_001202481.1. [Q13324-3]
DR   RefSeq; NP_001189411.1; NM_001202482.1. [Q13324-7]
DR   RefSeq; NP_001189412.1; NM_001202483.1. [Q13324-4]
DR   RefSeq; NP_001874.2; NM_001883.4. [Q13324-1]
DR   RefSeq; XP_011513430.1; XM_011515128.2.
DR   RefSeq; XP_011513431.1; XM_011515129.2.
DR   RefSeq; XP_016867241.1; XM_017011752.1. [Q13324-3]
DR   PDB; 3N93; X-ray; 2.50 A; A/B=3-104.
DR   PDB; 3N95; X-ray; 2.72 A; A/B/C/D=3-104.
DR   PDB; 3N96; X-ray; 2.75 A; A/B/C/D=3-104.
DR   PDB; 6PB1; EM; 2.80 A; P=2-388.
DR   PDBsum; 3N93; -.
DR   PDBsum; 3N95; -.
DR   PDBsum; 3N96; -.
DR   PDBsum; 6PB1; -.
DR   SMR; Q13324; -.
DR   BioGRID; 107785; 3.
DR   IntAct; Q13324; 2.
DR   MINT; Q13324; -.
DR   STRING; 9606.ENSP00000340943; -.
DR   BindingDB; Q13324; -.
DR   ChEMBL; CHEMBL4069; -.
DR   DrugCentral; Q13324; -.
DR   GuidetoPHARMACOLOGY; 213; -.
DR   GlyGen; Q13324; 5 sites.
DR   PhosphoSitePlus; Q13324; -.
DR   BioMuta; CRHR2; -.
DR   DMDM; 6226847; -.
DR   PaxDb; Q13324; -.
DR   PeptideAtlas; Q13324; -.
DR   PRIDE; Q13324; -.
DR   ProteomicsDB; 30449; -.
DR   ProteomicsDB; 59312; -. [Q13324-1]
DR   ProteomicsDB; 59313; -. [Q13324-2]
DR   ProteomicsDB; 59314; -. [Q13324-3]
DR   Antibodypedia; 12618; 622 antibodies.
DR   Ensembl; ENST00000341843; ENSP00000344304; ENSG00000106113. [Q13324-3]
DR   Ensembl; ENST00000348438; ENSP00000340943; ENSG00000106113. [Q13324-2]
DR   Ensembl; ENST00000471646; ENSP00000418722; ENSG00000106113. [Q13324-1]
DR   Ensembl; ENST00000506074; ENSP00000426498; ENSG00000106113. [Q13324-4]
DR   GeneID; 1395; -.
DR   KEGG; hsa:1395; -.
DR   UCSC; uc003tbn.4; human. [Q13324-1]
DR   CTD; 1395; -.
DR   DisGeNET; 1395; -.
DR   EuPathDB; HostDB:ENSG00000106113.18; -.
DR   GeneCards; CRHR2; -.
DR   HGNC; HGNC:2358; CRHR2.
DR   HPA; ENSG00000106113; Tissue enhanced (brain).
DR   MIM; 602034; gene.
DR   neXtProt; NX_Q13324; -.
DR   OpenTargets; ENSG00000106113; -.
DR   PharmGKB; PA26875; -.
DR   eggNOG; KOG4564; Eukaryota.
DR   GeneTree; ENSGT00940000156795; -.
DR   HOGENOM; CLU_002753_4_1_1; -.
DR   InParanoid; Q13324; -.
DR   KO; K04579; -.
DR   OMA; EFDVNCS; -.
DR   OrthoDB; 1163977at2759; -.
DR   PhylomeDB; Q13324; -.
DR   TreeFam; TF315710; -.
DR   PathwayCommons; Q13324; -.
DR   Reactome; R-HSA-373080; Class B/2 (Secretin family receptors).
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-422085; Synthesis, secretion, and deacylation of Ghrelin.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   BioGRID-ORCS; 1395; 3 hits in 864 CRISPR screens.
DR   ChiTaRS; CRHR2; human.
DR   EvolutionaryTrace; Q13324; -.
DR   GeneWiki; Corticotropin_releasing_hormone_receptor_2; -.
DR   GenomeRNAi; 1395; -.
DR   Pharos; Q13324; Tbio.
DR   PRO; PR:Q13324; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q13324; protein.
DR   Bgee; ENSG00000106113; Expressed in frontal cortex and 107 other tissues.
DR   ExpressionAtlas; Q13324; baseline and differential.
DR   Genevisible; Q13324; HS.
DR   GO; GO:0043679; C:axon terminus; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0015056; F:corticotrophin-releasing factor receptor activity; IBA:GO_Central.
DR   GO; GO:0043404; F:corticotropin-releasing hormone receptor activity; IBA:GO_Central.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0017046; F:peptide hormone binding; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IBA:GO_Central.
DR   Gene3D; 4.10.1240.10; -; 1.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR003053; GPCR_2_CRF2_rcpt.
DR   InterPro; IPR003051; GPCR_2_CRF_rcpt.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF02793; HRM; 1.
DR   PRINTS; PR01279; CRFRECEPTOR.
DR   PRINTS; PR01281; CRFRECEPTOR2.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00008; HormR; 1.
DR   SUPFAM; SSF111418; SSF111418; 1.
DR   PROSITE; PS00649; G_PROTEIN_RECEP_F2_1; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism; Receptor;
KW   Reference proteome; Signal; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..411
FT                   /note="Corticotropin-releasing factor receptor 2"
FT                   /id="PRO_0000012820"
FT   SIGNAL          1..19
FT                   /note="Not cleaved"
FT   TOPO_DOM        1..108
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        109..139
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        140..146
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        147..171
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        172..185
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        186..214
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        215..221
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        222..249
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        250..265
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        266..291
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        292..302
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        303..327
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        328..334
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        335..364
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        365..411
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        13
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        14..50
FT                   /evidence="ECO:0000269|PubMed:20966082"
FT   DISULFID        40..83
FT                   /evidence="ECO:0000269|PubMed:20966082"
FT   DISULFID        64..98
FT                   /evidence="ECO:0000269|PubMed:20966082"
FT   DISULFID        184..254
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..34
FT                   /note="MDAALLHSLLEANCSLALAEELLLDGWGPPLDPE -> MRGPSGPPGLLYVP
FT                   HLLLCLLCLLPPPLQYAAGQSQMPKDQPLWALLEQYCHTIMTLTNLS (in isoform
FT                   CRF2-beta)"
FT                   /evidence="ECO:0000303|PubMed:9199241, ECO:0000303|Ref.2"
FT                   /id="VSP_001999"
FT   VAR_SEQ         1..34
FT                   /note="MDAALLHSLLEANCSLALAEELLLDGWGPPLDPE -> MGREPWPEDRDLGF
FT                   PQLFCQ (in isoform CRF2-gamma)"
FT                   /evidence="ECO:0000303|PubMed:9717834"
FT                   /id="VSP_002000"
FT   VAR_SEQ         106
FT                   /note="Missing (in isoform desQ)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_053564"
FT   VAR_SEQ         366..411
FT                   /note="VRSAVRKRWHRWQDHHSLRVPMARAMSIPTSPTRISFHSIKQTAAV -> SW
FT                   VSKEAQAAGPHGREKPEQRW (in isoform D)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_053565"
FT   VAR_SEQ         366..411
FT                   /note="VRSAVRKRWHRWQDHHSLRVPMARAMSIPTSPTRISFHSIKQTAAV -> GL
FT                   EPV (in isoform E)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_053566"
FT   VAR_SEQ         367..411
FT                   /note="Missing (in isoform F)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_053567"
FT   VARIANT         220
FT                   /note="E -> D (in dbSNP:rs34625936)"
FT                   /id="VAR_049455"
FT   CONFLICT        185
FT                   /note="R -> H (in Ref. 1; AAA91320 and 6; ABV59313/
FT                   ABV59314/ABV59315/ABV59317)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374
FT                   /note="W -> R (in Ref. 7; BAG36414)"
FT                   /evidence="ECO:0000305"
FT   HELIX           111..140
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           147..170
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           174..178
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           182..213
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           219..221
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           224..231
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   TURN            232..236
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           237..247
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           253..255
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           266..297
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           301..315
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   TURN            316..320
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           321..324
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           334..349
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           351..360
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   HELIX           364..381
FT                   /evidence="ECO:0000244|PDB:6PB1"
FT   DISULFID        Q13324-2:51..77
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   411 AA;  47688 MW;  96B99A93594CF07F CRC64;
     MDAALLHSLL EANCSLALAE ELLLDGWGPP LDPEGPYSYC NTTLDQIGTC WPRSAAGALV
     ERPCPEYFNG VKYNTTRNAY RECLENGTWA SKINYSQCEP ILDDKQRKYD LHYRIALVVN
     YLGHCVSVAA LVAAFLLFLA LRSIRCLRNV IHWNLITTFI LRNVMWFLLQ LVDHEVHESN
     EVWCRCITTI FNYFVVTNFF WMFVEGCYLH TAIVMTYSTE RLRKCLFLFI GWCIPFPIIV
     AWAIGKLYYE NEQCWFGKEP GDLVDYIYQG PIILVLLINF VFLFNIVRIL MTKLRASTTS
     ETIQYRKAVK ATLVLLPLLG ITYMLFFVNP GEDDLSQIMF IYFNSFLQSF QGFFVSVFYC
     FFNGEVRSAV RKRWHRWQDH HSLRVPMARA MSIPTSPTRI SFHSIKQTAA V
//
ID   CRFR1_HUMAN             Reviewed;         444 AA.
AC   P34998; B4DIE9; Q13008; Q4QRJ1; Q9UK64;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   12-AUG-2020, entry version 203.
DE   RecName: Full=Corticotropin-releasing factor receptor 1;
DE            Short=CRF-R-1;
DE            Short=CRF-R1;
DE            Short=CRFR-1;
DE   AltName: Full=Corticotropin-releasing hormone receptor 1;
DE            Short=CRH-R-1;
DE            Short=CRH-R1;
DE   Flags: Precursor;
GN   Name=CRHR1; Synonyms=CRFR, CRFR1, CRHR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS CRF-R1 AND CRF-R2).
RC   TISSUE=Pituitary;
RX   PubMed=7692441; DOI=10.1073/pnas.90.19.8967;
RA   Chen R., Lewis K.A., Perrin M.H., Vale W.W.;
RT   "Expression cloning of a human corticotropin-releasing-factor receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:8967-8971(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF-R2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8243652; DOI=10.1016/0014-5793(93)80427-v;
RA   Vita N., Laurent P., Lefort S., Chalon P., Lelias J.-M., Kaghad M.,
RA   le Fur G., Caput D., Ferrara P.;
RT   "Primary structure and functional expression of mouse pituitary and human
RT   brain corticotrophin releasing factor receptors.";
RL   FEBS Lett. 335:1-5(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9757017; DOI=10.1016/s0378-1119(98)00322-9;
RA   Sakai K., Yamada M., Horiba N., Wakui M., Demura H., Suda T.;
RT   "The genomic organization of the human corticotropin-releasing factor type-
RT   1 receptor.";
RL   Gene 219:125-130(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF-R3).
RC   TISSUE=Hippocampus;
RX   PubMed=7811272; DOI=10.1006/bbrc.1994.2884;
RA   Ross P.C., Kostas C.M., Ramabhadran T.V.;
RT   "A variant of the human corticotropin-releasing factor (CRF) receptor:
RT   cloning, expression and pharmacology.";
RL   Biochem. Biophys. Res. Commun. 205:1836-1842(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CRF-R4).
RX   PubMed=10598591; DOI=10.1210/mend.13.12.0391;
RA   Grammatopoulos D.K., Dai Y., Randeva H.S., Levine M.A., Karteris E.,
RA   Easton A.J., Hillhouse E.W.;
RT   "A novel spliced variant of the type 1 corticotropin-releasing hormone
RT   receptor with a deletion in the seventh transmembrane domain present in the
RT   human pregnant term myometrium and fetal membranes.";
RL   Mol. Endocrinol. 13:2189-2202(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Sherrin T., Murthy S.R., Spiess J.;
RT   "A novel CRF1 splice isoform involved in neurodegenerative and stress
RT   disorders.";
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF-R2).
RC   TISSUE=Brain;
RA   King M.M., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF-R2).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CRF-R2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 24-31, AND DISULFIDE BONDS.
RX   PubMed=11425856; DOI=10.1074/jbc.m101838200;
RA   Perrin M.H., Fischer W.H., Kunitake K.S., Craig A.G., Koerber S.C.,
RA   Cervini L.A., Rivier J.E., Groppe J.C., Greenwald J., Moller Nielsen S.,
RA   Vale W.W.;
RT   "Expression, purification, and characterization of a soluble form of the
RT   first extracellular domain of the human type 1 corticotropin releasing
RT   factor receptor.";
RL   J. Biol. Chem. 276:31528-31534(2001).
RN   [14]
RP   PHOSPHORYLATION AT SER-330.
RX   PubMed=14657255; DOI=10.1210/me.2003-0365;
RA   Papadopoulou N., Chen J., Randeva H.S., Levine M.A., Hillhouse E.W.,
RA   Grammatopoulos D.K.;
RT   "Protein kinase A-induced negative regulation of the corticotropin-
RT   releasing hormone R1alpha receptor-extracellularly regulated kinase signal
RT   transduction pathway: the critical role of Ser301 for signaling switch and
RT   selectivity.";
RL   Mol. Endocrinol. 18:624-639(2004).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18292205; DOI=10.1124/mol.107.043612;
RA   Tao J., Hildebrand M.E., Liao P., Liang M.C., Tan G., Li S., Snutch T.P.,
RA   Soong T.W.;
RT   "Activation of corticotropin-releasing factor receptor 1 selectively
RT   inhibits CaV3.2 T-type calcium channels.";
RL   Mol. Pharmacol. 73:1596-1609(2008).
RN   [16]
RP   INTERACTION WITH CRF AND UCN.
RX   PubMed=20966082; DOI=10.1074/jbc.m110.186072;
RA   Pal K., Swaminathan K., Xu H.E., Pioszak A.A.;
RT   "Structural basis for hormone recognition by the Human CRFR2{alpha} G
RT   protein-coupled receptor.";
RL   J. Biol. Chem. 285:40351-40361(2010).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DLG1.
RX   PubMed=23576434; DOI=10.1074/jbc.m113.473660;
RA   Dunn H.A., Walther C., Godin C.M., Hall R.A., Ferguson S.S.;
RT   "Role of SAP97 protein in the regulation of corticotropin-releasing factor
RT   receptor 1 endocytosis and extracellular signal-regulated kinase 1/2
RT   signaling.";
RL   J. Biol. Chem. 288:15023-15034(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 24-119 IN COMPLEX WITH CRH,
RP   FUNCTION, AND DISULFIDE BONDS.
RX   PubMed=18801728; DOI=10.1074/jbc.m805749200;
RA   Pioszak A.A., Parker N.R., Suino-Powell K., Xu H.E.;
RT   "Molecular recognition of corticotropin-releasing factor by its G-protein-
RT   coupled receptor CRFR1.";
RL   J. Biol. Chem. 283:32900-32912(2008).
RN   [19]
RP   STRUCTURE BY NMR OF 25-109 IN COMPLEX WITH SYNTHETIC CRH ANALOG.
RX   PubMed=20843795; DOI=10.1074/jbc.m110.121897;
RA   Grace C.R., Perrin M.H., Gulyas J., Rivier J.E., Vale W.W., Riek R.;
RT   "NMR structure of the first extracellular domain of corticotropin-releasing
RT   factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist.";
RL   J. Biol. Chem. 285:38580-38589(2010).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.98 ANGSTROMS) OF 104-373 IN COMPLEX WITH THE
RP   SYNTHETIC ANTAGONIST CP-376395, FUNCTION, SUBCELLULAR LOCATION, MEMBRANE
RP   TOPOLOGY, DISULFIDE BOND, ANTAGONIST BINDING SITES, AND MUTAGENESIS OF
RP   PHE-232; MET-235; LEU-309; ASN-312; PHE-313; LEU-316; ILE-319; TYR-356 AND
RP   GLN-384.
RX   PubMed=23863939; DOI=10.1038/nature12357;
RA   Hollenstein K., Kean J., Bortolato A., Cheng R.K., Dore A.S., Jazayeri A.,
RA   Cooke R.M., Weir M., Marshall F.H.;
RT   "Structure of class B GPCR corticotropin-releasing factor receptor 1.";
RL   Nature 499:438-443(2013).
CC   -!- FUNCTION: G-protein coupled receptor for CRH (corticotropin-releasing
CC       factor) and UCN (urocortin). Has high affinity for CRH and UCN. Ligand
CC       binding causes a conformation change that triggers signaling via
CC       guanine nucleotide-binding proteins (G proteins) and down-stream
CC       effectors, such as adenylate cyclase. Promotes the activation of
CC       adenylate cyclase, leading to increased intracellular cAMP levels.
CC       Inhibits the activity of the calcium channel CACNA1H. Required for
CC       normal embryonic development of the adrenal gland and for normal
CC       hormonal responses to stress. Plays a role in the response to
CC       anxiogenic stimuli. {ECO:0000269|PubMed:18292205,
CC       ECO:0000269|PubMed:18801728, ECO:0000269|PubMed:23576434,
CC       ECO:0000269|PubMed:23863939}.
CC   -!- SUBUNIT: Heterodimer; heterodimerizes with GPER1 (By similarity).
CC       Interacts (via N-terminal extracellular domain) with CRH and UCN.
CC       Interacts with DLG1; this inhibits endocytosis of CRHR1 after agonist
CC       binding. {ECO:0000250, ECO:0000269|PubMed:18801728,
CC       ECO:0000269|PubMed:20843795, ECO:0000269|PubMed:20966082,
CC       ECO:0000269|PubMed:23576434, ECO:0000269|PubMed:23863939}.
CC   -!- INTERACTION:
CC       P34998; P06850: CRH; NbExp=2; IntAct=EBI-3870393, EBI-3870390;
CC       P34998; Q12959: DLG1; NbExp=2; IntAct=EBI-3870393, EBI-357481;
CC       P34998; Q14160: SCRIB; NbExp=3; IntAct=EBI-3870393, EBI-357345;
CC       P34998; Q63622: Dlg2; Xeno; NbExp=2; IntAct=EBI-3870393, EBI-396947;
CC       P34998; O88382: Magi2; Xeno; NbExp=2; IntAct=EBI-3870393, EBI-696179;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Endosome. Note=Agonist-binding promotes endocytosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=CRF-R1;
CC         IsoId=P34998-1; Sequence=Displayed;
CC       Name=CRF-R2;
CC         IsoId=P34998-2; Sequence=VSP_001997;
CC       Name=CRF-R3;
CC         IsoId=P34998-3; Sequence=VSP_001996, VSP_001997;
CC       Name=CRF-R4; Synonyms=1D;
CC         IsoId=P34998-4; Sequence=VSP_001997, VSP_001998;
CC       Name=5;
CC         IsoId=P34998-5; Sequence=VSP_045434;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the cerebellum,
CC       pituitary, cerebral cortex and olfactory lobe.
CC       {ECO:0000269|PubMed:8243652}.
CC   -!- DOMAIN: The transmembrane domain is composed of seven transmembrane
CC       helices that are arranged in V-shape. Transmembrane helix 7 assumes a
CC       sharply kinked structure. The antagonist CP-376395 binds at an
CC       allosteric site, far from the presumed binding site for the
CC       physiological peptide ligand.
CC   -!- PTM: C-terminal Ser or Thr residues may be phosphorylated.
CC       {ECO:0000269|PubMed:14657255}.
CC   -!- PTM: Phosphorylation at Ser-330 by PKA prevents maximal coupling to Gq-
CC       protein, and thereby negatively regulates downstream signaling.
CC       {ECO:0000269|PubMed:14657255}.
CC   -!- MISCELLANEOUS: [Isoform CRF-R2]: Major isoform. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform CRF-R3]: Does not bind to CRF with high
CC       affinity. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L23333; AAA35719.1; -; mRNA.
DR   EMBL; L23332; AAA35718.1; -; mRNA.
DR   EMBL; X72304; CAA51052.1; -; mRNA.
DR   EMBL; AF039523; AAC69993.1; -; Genomic_DNA.
DR   EMBL; AF039510; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039511; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039512; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039513; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039514; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039515; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039516; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039517; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039518; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039519; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039520; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039521; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; AF039522; AAC69993.1; JOINED; Genomic_DNA.
DR   EMBL; U16273; AAC50073.1; -; mRNA.
DR   EMBL; AF180301; AAD52688.1; -; mRNA.
DR   EMBL; FJ543100; ACU68591.1; -; mRNA.
DR   EMBL; AY457172; AAR19768.1; -; mRNA.
DR   EMBL; AB451466; BAG70280.1; -; mRNA.
DR   EMBL; AK295559; BAG58461.1; -; mRNA.
DR   EMBL; AC126544; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC217770; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC217771; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC217774; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC225613; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471233; EAW93557.1; -; Genomic_DNA.
DR   EMBL; BC096836; AAH96836.1; -; mRNA.
DR   CCDS; CCDS42350.1; -. [P34998-2]
DR   CCDS; CCDS45712.1; -. [P34998-1]
DR   CCDS; CCDS45713.1; -. [P34998-4]
DR   CCDS; CCDS45714.1; -. [P34998-3]
DR   CCDS; CCDS58556.1; -. [P34998-5]
DR   PIR; I38879; I38879.
DR   PIR; I60975; A48260.
DR   RefSeq; NP_001138618.1; NM_001145146.1. [P34998-1]
DR   RefSeq; NP_001138619.1; NM_001145147.1. [P34998-3]
DR   RefSeq; NP_001138620.1; NM_001145148.1. [P34998-4]
DR   RefSeq; NP_001243228.1; NM_001256299.2. [P34998-5]
DR   RefSeq; NP_001289945.1; NM_001303016.1.
DR   RefSeq; NP_001289947.1; NM_001303018.1. [P34998-5]
DR   RefSeq; NP_004373.2; NM_004382.4. [P34998-2]
DR   PDB; 2L27; NMR; -; A=25-108.
DR   PDB; 3EHS; X-ray; 2.76 A; A=24-119.
DR   PDB; 3EHT; X-ray; 3.40 A; A=24-119.
DR   PDB; 3EHU; X-ray; 1.96 A; A/B=24-119.
DR   PDB; 4K5Y; X-ray; 2.98 A; A/B/C=104-373.
DR   PDB; 4Z9G; X-ray; 3.18 A; A/B/C=104-249, A/B/C=252-401.
DR   PDB; 6P9X; EM; 2.91 A; R=23-444.
DR   PDB; 6PB0; EM; 3.00 A; R=24-427.
DR   PDBsum; 2L27; -.
DR   PDBsum; 3EHS; -.
DR   PDBsum; 3EHT; -.
DR   PDBsum; 3EHU; -.
DR   PDBsum; 4K5Y; -.
DR   PDBsum; 4Z9G; -.
DR   PDBsum; 6P9X; -.
DR   PDBsum; 6PB0; -.
DR   SMR; P34998; -.
DR   BioGRID; 107784; 18.
DR   IntAct; P34998; 7.
DR   MINT; P34998; -.
DR   STRING; 9606.ENSP00000381333; -.
DR   BindingDB; P34998; -.
DR   ChEMBL; CHEMBL1800; -.
DR   DrugBank; DB09067; Corticorelin ovine triflutate.
DR   DrugCentral; P34998; -.
DR   GuidetoPHARMACOLOGY; 212; -.
DR   TCDB; 9.A.14.4.3; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; P34998; 5 sites.
DR   iPTMnet; P34998; -.
DR   PhosphoSitePlus; P34998; -.
DR   BioMuta; CRHR1; -.
DR   DMDM; 461836; -.
DR   PaxDb; P34998; -.
DR   PeptideAtlas; P34998; -.
DR   PRIDE; P34998; -.
DR   ProteomicsDB; 4300; -.
DR   ProteomicsDB; 54968; -. [P34998-1]
DR   ProteomicsDB; 54969; -. [P34998-2]
DR   ProteomicsDB; 54970; -. [P34998-3]
DR   ProteomicsDB; 54971; -. [P34998-4]
DR   Antibodypedia; 8417; 369 antibodies.
DR   DNASU; 1394; -.
DR   Ensembl; ENST00000314537; ENSP00000326060; ENSG00000120088. [P34998-2]
DR   Ensembl; ENST00000352855; ENSP00000344068; ENSG00000120088. [P34998-3]
DR   Ensembl; ENST00000398285; ENSP00000381333; ENSG00000120088. [P34998-1]
DR   Ensembl; ENST00000577353; ENSP00000462016; ENSG00000120088. [P34998-4]
DR   Ensembl; ENST00000616274; ENSP00000480396; ENSG00000276191. [P34998-1]
DR   Ensembl; ENST00000616748; ENSP00000478177; ENSG00000276191. [P34998-3]
DR   Ensembl; ENST00000617905; ENSP00000483802; ENSG00000276191. [P34998-2]
DR   Ensembl; ENST00000633723; ENSP00000488342; ENSG00000276191. [P34998-4]
DR   GeneID; 104909134; -.
DR   GeneID; 1394; -.
DR   KEGG; hsa:104909134; -.
DR   KEGG; hsa:1394; -.
DR   UCSC; uc002ijm.4; human. [P34998-1]
DR   CTD; 104909134; -.
DR   CTD; 1394; -.
DR   DisGeNET; 104909134; -.
DR   DisGeNET; 1394; -.
DR   EuPathDB; HostDB:ENSG00000120088.14; -.
DR   GeneCards; CRHR1; -.
DR   HGNC; HGNC:2357; CRHR1.
DR   HPA; ENSG00000120088; Group enriched (brain, pituitary gland).
DR   MIM; 122561; gene.
DR   neXtProt; NX_P34998; -.
DR   OpenTargets; ENSG00000120088; -.
DR   OpenTargets; ENSG00000263715; -.
DR   PharmGKB; PA26874; -.
DR   eggNOG; KOG4564; Eukaryota.
DR   GeneTree; ENSGT00940000158410; -.
DR   InParanoid; P34998; -.
DR   KO; K04578; -.
DR   OMA; VHYHIAV; -.
DR   OrthoDB; 1163977at2759; -.
DR   PhylomeDB; P34998; -.
DR   TreeFam; TF315710; -.
DR   PathwayCommons; P34998; -.
DR   Reactome; R-HSA-373080; Class B/2 (Secretin family receptors).
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SIGNOR; P34998; -.
DR   BioGRID-ORCS; 104909134; 1 hit in 14 CRISPR screens.
DR   BioGRID-ORCS; 1394; 4 hits in 863 CRISPR screens.
DR   EvolutionaryTrace; P34998; -.
DR   GeneWiki; Corticotropin_releasing_hormone_receptor_1; -.
DR   Pharos; P34998; Tclin.
DR   PRO; PR:P34998; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P34998; protein.
DR   Bgee; ENSG00000120088; Expressed in pituitary gland and 86 other tissues.
DR   ExpressionAtlas; P34998; baseline and differential.
DR   Genevisible; P34998; HS.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0015056; F:corticotrophin-releasing factor receptor activity; IDA:UniProtKB.
DR   GO; GO:0051424; F:corticotropin-releasing hormone binding; IBA:GO_Central.
DR   GO; GO:0043404; F:corticotropin-releasing hormone receptor activity; IBA:GO_Central.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0017046; F:peptide hormone binding; IBA:GO_Central.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0071376; P:cellular response to corticotropin-releasing hormone stimulus; IDA:UniProtKB.
DR   GO; GO:0051458; P:corticotropin secretion; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; NAS:ProtInc.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:1901386; P:negative regulation of voltage-gated calcium channel activity; IDA:UniProtKB.
DR   GO; GO:0007567; P:parturition; TAS:ProtInc.
DR   GO; GO:0010578; P:regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:2000852; P:regulation of corticosterone secretion; ISS:UniProtKB.
DR   Gene3D; 4.10.1240.10; -; 1.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR003052; GPCR_2_CRF1_rcpt.
DR   InterPro; IPR003051; GPCR_2_CRF_rcpt.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF02793; HRM; 1.
DR   PRINTS; PR01279; CRFRECEPTOR.
DR   PRINTS; PR01280; CRFRECEPTOR1.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00008; HormR; 1.
DR   SUPFAM; SSF111418; SSF111418; 1.
DR   PROSITE; PS00649; G_PROTEIN_RECEP_F2_1; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Endosome;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Signal; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:11425856"
FT   CHAIN           24..444
FT                   /note="Corticotropin-releasing factor receptor 1"
FT                   /id="PRO_0000012814"
FT   TOPO_DOM        24..111
FT                   /note="Extracellular"
FT   TRANSMEM        112..142
FT                   /note="Helical; Name=1"
FT   TOPO_DOM        143..178
FT                   /note="Cytoplasmic"
FT   TRANSMEM        179..203
FT                   /note="Helical; Name=2"
FT   TOPO_DOM        204..218
FT                   /note="Extracellular"
FT   TRANSMEM        219..247
FT                   /note="Helical; Name=3"
FT   TOPO_DOM        248..254
FT                   /note="Cytoplasmic"
FT   TRANSMEM        255..282
FT                   /note="Helical; Name=4"
FT   TOPO_DOM        283..298
FT                   /note="Extracellular"
FT   TRANSMEM        299..324
FT                   /note="Helical; Name=5"
FT   TOPO_DOM        325..335
FT                   /note="Cytoplasmic"
FT   TRANSMEM        336..360
FT                   /note="Helical; Name=6"
FT   TOPO_DOM        361..367
FT                   /note="Extracellular"
FT   TRANSMEM        368..397
FT                   /note="Helical; Name=7"
FT   TOPO_DOM        398..444
FT                   /note="Cytoplasmic"
FT   REGION          99..108
FT                   /note="Important for peptide agonist binding"
FT   REGION          309..319
FT                   /note="Important for antagonist binding"
FT   MOD_RES         330
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:14657255"
FT   CARBOHYD        38
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        78
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        90
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        30..54
FT   DISULFID        44..87
FT   DISULFID        68..102
FT   DISULFID        217..287
FT   VAR_SEQ         1..204
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.6"
FT                   /id="VSP_045434"
FT   VAR_SEQ         41..81
FT                   /note="GLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTN -> D (in
FT                   isoform CRF-R3)"
FT                   /evidence="ECO:0000303|PubMed:7811272"
FT                   /id="VSP_001996"
FT   VAR_SEQ         146..174
FT                   /note="Missing (in isoform CRF-R2, isoform CRF-R3 and
FT                   isoform CRF-R4)"
FT                   /evidence="ECO:0000303|PubMed:10598591,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:19054851,
FT                   ECO:0000303|PubMed:7692441, ECO:0000303|PubMed:7811272,
FT                   ECO:0000303|PubMed:8243652, ECO:0000303|Ref.7"
FT                   /id="VSP_001997"
FT   VAR_SEQ         385..398
FT                   /note="Missing (in isoform CRF-R4)"
FT                   /evidence="ECO:0000303|PubMed:10598591"
FT                   /id="VSP_001998"
FT   MUTAGEN         232
FT                   /note="F->A: Nearly abolishes antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         235
FT                   /note="M->A: Strongly reduces antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         309
FT                   /note="L->A: Nearly abolishes antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         312
FT                   /note="N->A: Nearly abolishes antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         313
FT                   /note="F->A: Slightly reduces antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         316
FT                   /note="L->A: Strongly reduces antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         319
FT                   /note="I->A: Strongly reduces antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         356
FT                   /note="Y->A: Strongly reduces antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   MUTAGEN         384
FT                   /note="Q->A: Increases antagonist binding."
FT                   /evidence="ECO:0000269|PubMed:23863939"
FT   TURN            25..27
FT                   /evidence="ECO:0000244|PDB:3EHT"
FT   HELIX           28..32
FT                   /evidence="ECO:0000244|PDB:3EHU"
FT   STRAND          49..52
FT                   /evidence="ECO:0000244|PDB:2L27"
FT   STRAND          62..67
FT                   /evidence="ECO:0000244|PDB:3EHU"
FT   STRAND          70..74
FT                   /evidence="ECO:0000244|PDB:3EHU"
FT   STRAND          81..87
FT                   /evidence="ECO:0000244|PDB:3EHU"
FT   TURN            89..91
FT                   /evidence="ECO:0000244|PDB:2L27"
FT   STRAND          93..98
FT                   /evidence="ECO:0000244|PDB:3EHS"
FT   HELIX           99..101
FT                   /evidence="ECO:0000244|PDB:2L27"
FT   HELIX           103..107
FT                   /evidence="ECO:0000244|PDB:3EHS"
FT   HELIX           114..143
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           175..177
FT                   /evidence="ECO:0000244|PDB:4K5Y"
FT   HELIX           179..203
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           207..212
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           215..235
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           237..247
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   STRAND          249..252
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           257..264
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   TURN            265..267
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           268..281
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           286..288
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           299..330
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           334..347
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           349..352
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           355..358
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           367..382
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           384..392
FT                   /evidence="ECO:0000244|PDB:6P9X"
FT   HELIX           397..408
FT                   /evidence="ECO:0000244|PDB:6P9X"
SQ   SEQUENCE   444 AA;  50719 MW;  7221AEFB0E7AA8ED CRC64;
     MGGHPQLRLV KALLLLGLNP VSASLQDQHC ESLSLASNIS GLQCNASVDL IGTCWPRSPA
     GQLVVRPCPA FFYGVRYNTT NNGYRECLAN GSWAARVNYS ECQEILNEEK KSKVHYHVAV
     IINYLGHCIS LVALLVAFVL FLRLRPGCTH WGDQADGALE VGAPWSGAPF QVRRSIRCLR
     NIIHWNLISA FILRNATWFV VQLTMSPEVH QSNVGWCRLV TAAYNYFHVT NFFWMFGEGC
     YLHTAIVLTY STDRLRKWMF ICIGWGVPFP IIVAWAIGKL YYDNEKCWFG KRPGVYTDYI
     YQGPMILVLL INFIFLFNIV RILMTKLRAS TTSETIQYRK AVKATLVLLP LLGITYMLFF
     VNPGEDEVSR VVFIYFNSFL ESFQGFFVSV FYCFLNSEVR SAIRKRWHRW QDKHSIRARV
     ARAMSIPTSP TRVSFHSIKQ STAV
//
